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INTRODUCTION  
 
Siddha system which is an ancient medical system on par with the Ayurvedic 
system and mainly practiced in south India, is the natural based system, it has the 
basic principle that is “Unave marunthu”According to the literature,the systemwhich 
maintains the human body by three humours (Vaatham, Piththam, Kabam). These are 
the basic aliments to equilibrium of human Body’s constitutions which seven in 
nature named as Saaram, Senneer, Oon, Kozhuppu, Enbu, Moolai,Venner. Any 
derangement of the three humours and seven constitutions will result in the disease. In 
these modern world, change in life style and food habits play an important role in 
altering the normalcy of these three humours resulting in chronic diseases and 
discomforts in the body.  
 
          In antient tamilnadu, Toddy also called as pizhi,theral, ariyal .Yavanar who 
prepare the toddy, it was taken by tamil people. They take toddy along with honey, 
rice, and millet etc. Especially before enter to the battle ground the warier should take 
toddy along with fresh meet for the purpose to theft cattle. 
 
 
 
As per Siddha text KUDIVERI NOI (MATHATHIYAM) is one of the 
psychiatric condition, caused by over consumption of liquor like things and non-
vegetarian food followed by the symptoms of Intoxication, sweating, weakness, 
tremor, sleep disturbance, psychiatric problems, loss of appetite, vomiting. These 
symptoms can be correlated with chronic alcoholism(alcoholic dependence).  
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“
 
 
 Nanthesar agaalamarana nool 
 
According to the text Nanthesar agalamarana nool, due to over consumption of 
alcohol or arrack, the ill effects like dizziness, uncoordinated gait, reddishness of face, 
blurred vision, blabbering of speech, mental confusion and disturbance will be noted. 
Nadi (Pulse) won’t be correctly perceivable or will be in irregular rhythm, during this 
period as described by the siddha medical literature. While taking high forms of 
medication (eg.Parpam, chenduram, mezhugu) one should avoid any alcoholic 
beverages, the same should not be given to such individuals.  
 
According to World health organization (ICD-10), Alcoholism is 
characterized by   Intoxication, harmful use, alcoholic dependence, withdrawal 
symptoms (tremor, nausea, vomiting, sleep disturbance, anxiety) and psychotic 
disorders. Alcohol misuse has the potential to damage almost every organ in the body, 
including the brain. The cumulative toxic effects of chronic alcohol abuse can cause 
both medical and psychiatric problems. Long-term alcohol consumption also causes 
phrenopathy and social effects, such as violent crimes and traffic accidents.  
 
The WHO also estimates that as of 2010 were 208 million people with 
alcoholism.  The harmful use of alcohol causes death of about 3.3 million people 
worldwide annually. There are 60 different types of diseases where alcohol has a 
significant causal role. It also causes harm to the well-being and health of people 
around the drinker. In India, the estimated numbers of alcohol users in 2005 were 62.5 
million, with 17.4% of them (10.6 million) being dependent users and 20-30% of 
hospital admissions are due to alcohol-related problems. Few studies have 
documented the pattern and profile of alcohol use and its impact in hospital and 
population-based settings.   
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However, it is known that these modern chemical drugs lead to abuse, psychological 
dependence and adverse behavioral effects. These drugs could also lead to 
physiological dependence when taken chronically and result in dose escalation.  
 
Despite great progress made in the past two decades, the development of low toxicity 
and high efficiency medicines remains a challenging task for alcohol researchers.  
 
 Many herbal and herbo-mineral treatment practice are mentioned for de-addiction in 
Siddha system of medicine. The author has chosen INJI CHOORANAM for this study 
with relevance of symptoms present in alcoholic dependent patients.   
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AIM  
 
To evaluate the therapeutic efficacy of Inji Choornam for the treatment of 
 Kudiveri Noi (Chronic alcoholism) 
 
OBJECTIVES: 
PRIMARY OBJECTIVE: 
To evaluate the therapeutic efficacy of Inji Choornam for the treatment of 
 Kudiveri Noi (Chronic alcoholism) 
 
SECONDARY OBJECTIVES:   
 
• To do Biochemical analysis of the trial drugs. 
• To evaluate the clinical symptoms, before and after the treatment 
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Review of Literature 
SIDDHA ASPECTS OF KUDIVERI NOI 
 
Definition: 
 Consciousness will turn, gossip speech, and the seven constituents of body 
also fat, semen, ovum will be affected one by one due to over consumption of alcohol, 
arrack or fermented juice. 
 
Aetiology: 
 Over consumption of alcohol, country arrack and fermented juice for a long 
time 
 
Clinical features: 
  There are four stages of alcoholic intoxication 
a. First Stage: 
Its characterized by one of the groceries is a kind of 
excitement, encouragement, exhilaration, and reminiscent of 
the forgetfulness of the past, such as the body's warmth and 
physical strength  
 
b. Second Stage: 
The mood elevation and strength will be slowly 
decreasing and due to lack of co-ordination the person will be 
behaving madly and short tempered, scolding and attacking 
other, immoral behaviours and finally become unconscious 
 
c. Third Stage: 
The large amount of alcohol consumption produces 
changes in the person’s behaviour, which is became most 
aggressive and disrespect to others. The person will exhibit all 
kinds of physiognomy. 
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d. Fourth Stage: 
Its characterised by destruction of physical and mental 
health. Fell down without conscious. Chillness and over 
sweating of all over the body. Sometimes this leads to fatal 
condition.  
 
Other clinical signs and symptoms:  
 
➢ Dryness of mouth  
➢ Aversion to Food  
➢ Pain over the region of chest to vertex  
➢ Tremor and Sweating 
➢ Chest pain  
➢ Blurred vision  
➢ Cough, wheezing   
➢ Sleep disturbances  
➢ Mental incoordination and horrible dreams 
➢ Vomiting   
➢ Giddiness 
In the text, “Nandeesar Agaala marana nool” indicates the features of 
over intoxication of alcohol are as follow 
Over consumption of alcohol leads to diarrhea, hyperhidrosis, 
vomiting, loss of consciousness 
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giddiness, irrelevant movements, face becomes reddish, blabbered and 
irrelevant speech and mental disturbances are due to over in taking of alcohol 
The person shouts and fall down unconsciously respiration becomes 
shallow and feeble, cough with sputum is common, Giddiness, frothy saliva, 
pallor and eyes looking upwards, The sting odor of alcohol from mouth and 
nose.  
 
 
Eyes becomes reddish, loss of neck control, bloating of abdomen, 
blackish discoloration of tooth and tongue. 
 
Mathathyam: 
  It is otherwise known as mathaazhivu, mathakeedu. In this disease 
vinthunaatham , kaamaneer ,kozhuppu  are defeatected leads to defeat health. It 
classified into vaatham,  pitham, kabham and mukkutram based on three humoural 
divisions. In addition to Udarkedu (Thummicham) and Vanmai kedu (Vichayam) 
were also included.  So totally6 in divisions 
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1. Vali matha azhivu: 
Sleeplessness, Difficulty to Breathing, headache, involuntary 
movements, bad dreams, speaking with devil or demons are clinical features 
of vali matha azhivu   
2. Pitha matha azhivu: 
Greenish or yellowish discoloration of body, cheeks and eyes 
became reddish, Fever, burning eyes, sweating, loose stools, thrust, 
mental disturbances more common 
3. Kapha matha azhivu: 
Chest discomfort, over sleeping, vomiting, swelling of the body  
4. Mukuttra matha azhivu: 
It may show companied features of vali, azhal, iya matha 
azhivu 
5. Udarkedu: 
This is occurs by over intake of alcohol and non-veg products, 
phlegm accumulation in mouth, dryness of chest, over sleeping and 
laziness are findings of the characters of this disease. This progress to 
degeneration of the body thus termed as udarkedu 
6. Vanmai Kedu: 
Acute pain in the region of body, vertex and chest, congested 
feeling of throat region, tiredness, cough thirst, vomiting, pyrexia are 
the other common features. This progress to diminution of health and 
emaciation of the body thus termed as vanmai kedu 
SECONDARY DISEASE ASSOCIATED WITH KUDIVERI NOI: 
1) Madhu irumal (Kal Irumal) :(Cirrhosis of liver with portal hypertension) 
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Excessive intake of arrack, alcohol will produce itching in whole 
body, Ulcer formation in throat, gums and stomach by local irritation, 
General weakness also seen 
2) Mantha katti (Alcoholic liver disease) 
3) Unmatham (Hallucination) 
According to Yogi vaithiya chinthamani, alcoholism is one of the 
cause of unmantham 
4) Serukku noi (Cognitive impairment) 
5) Pakkavaatham (Hemiplegia) 
Naadi (pulse) variation due to alcoholism: 
The above lines are indicating that pulse can’t identified in an alcoholic 
 
Identification of corpse to find the signs of death due to alcoholism: 
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Reddish eyes, watery sputum expelled from mouth, upward 
looking eyes, hemoptysis with foul smelled froth and shrunken of male 
Types of Kal(Toddy): 
  There are so many toddies are used for abuse and medicines also 
1)Thenangal (coconut toddy): 
 Consumption of coconut toddy leads to Anaemia, dropsy, vatha pitha 
disease, dysentery, eczema, confusion of mind.  
 
Action: 
 Aphrodisiac When this toddy becomes sour it increases Aphrodisiac 
activity and loss of hearing and frequent consumption of coconut toddy for 
long time leads to many diseases.  
 
2) Panangal (palm toddy): 
Palm toddy used to cure body heat. It gives strength to seven body 
constitutions and also used for aphrodisiac action. Some of the toxic substance 
like veeram, pooram is purified by using palm toddy.  
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3) Eachangal (Toddy of date palm): 
 Eachangal reduces body heat, incontinence of urine, tasteless and 
swelling.  
 
4)Athhi kal (Fig toddy): 
Suvai     :  Innipu  
Thanmai :  thatpam  
Pirivu     :  Innipu  
Seikai     :  udal thetri.  
 
 
The toddy secretion from the root of fig tree along with sugar or 
banana is consumed in the early morning reduces the body heat, giddiness, 
thirst and bone disorders. They are also used as adjuvants.  
 
Medicinal uses of Toddy:  
Toddy which is obtained from the plants are used in aliments and as an 
Immuno boosters, to get relief from cold weather.  
 
Adjuvants:  
Toddy is used as adjuvants for some of the medicines like Eggu 
parpam, Ayakantha chenduram, Ayaparpam, velli chenduram, kanthaga 
parpam.  
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Role of toddy in detoxification:  
It is used as antidote for some of the toxic substances like Veeream 
(Hydrargyrum perchloride corrosive sublimate)  
 
Quality analysis of parpam:  
To define the quality of Eggu parpam which is made, according to the 
methods of sage Theran the prepared medicine is added to any one of 
panangal, thengal & echangal, which turn toddy to juice.  
 
Diet regiment: 
 Panangal, thennagal,eachengal and country arrack is used as a dietary 
regiment along with higher form of medicines is given for the treatment. eg. 
Sarvavidathodari, Ayam and Rasa parpam . 
 
Adverse effects of toddy:  
 
 
When it is illegitimately or excessively used it leads to kudiveri noi.  
 
Thirukural-(kallunamai):  
Saint Thiruvalluvar’s divine work “Thirukural”emphasizes the advice 
effects of consuming alcohol beverage, which is not only affects the health 
and also affects social well-being. 
  
Those who always thirst after drink will neither inspire fear (in others) 
nor retain the light (of their same).  
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” To give money and purchase unconsciousness is the result of one’s 
ignorance of (one’s own actions)  
 
Reasoning with a drunkard is like going under water with a torch in 
search of a drowned man. 
 
   
Intoxication is painful even in the presence of (ones) mother what will 
it not then be in that of the wise  
 
Historical reference regarding usage of alcohol: 
 
 The preparation on made with fig flower, palm jaggry along with 
some ingredients were used as toddy fow mirth   
 
“
 
 
 
MUKKUTTRAVERUPADUGAL:             
Human body is influenced by three Thaathus (Vital humours) such as 
Vaatham, Pitham and Kapham. They are responsible for normal physiological 
conditions of the body.  
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InKudiveri Noi (KVN), the following Mukkutram are commonly affected,  
 
Vaatham: 
 1. Abanan  -  Habitual Constipation/ diarrhoea  
2. Uthanan  -   Nausea, vomiting  
3. Viyanan  -  Weakness, tremor.  
 4. Samanan  -  Due to other vaayus, it is affected  
5. Kirukaran  - Loss of appetite 
 6. Devathathan  - Insomnia, Irritability, Agitation  
 
Pitham: 
1.Aakkanal - Indigestion of food  
2. Vanna eri - Paleness/ yellowish discoloration of the conjunctiva and 
tongue 
3.Aatralangi - Depression, Confusion, Fear, loss of employment, 
Isolation from family  
4.Olloli thee - Dryness and roughness of skin   
 
Kabam: 
1. Neerpiyaiyam  -  Loss of appetite  
2. Niraivaiyam  -  Burning sensation of eyes may be present  
3. Ondriyaiyam  -  Joint pain present in very few cases  
 
Udalthathukkal: 
   Our body consists of seven Udal thathukkal(body constitution). It 
gives strength and structure to our body. In Kudiveri noi patients, Saaram, 
Senneer, Kozhuppu and Enbu are commonly affected.   
1. Saaram :  Dryness, roughness, tiredness   
2. Senneer  :Hyperpigmented patches may present   
3. Kozhuppu  :Polycythaemia can occur   
4. Enbu            :  Joint pain present in few cases       
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Udalvanmai: 
 It is classified into 3 types, they are, 
  1) Iyarkai Vanmai Natural immunity of the body by birth  
2) Seyarkai Vanmai Improving the health by intake of nutritious food 
materials and medicines. 
3)Kaala VanmaiDevelopment of immunity according to age and the 
environment. 
 
Imporigal: 
1) Mei - Roughness of the skin.  
Kanmenthriyam : 
1)Vaai(mouth) -Slurred speech 
2) Eruvaai(Anal orifice) -diarrhoea 
3) Karuvai(genital orifice) - Impotency 
 
Piniyariyum Muraimai (Diagnostic Methods): 
Piniyariyum muraimai is the method of diagnosing disease. It is based 
on the following principles: 
▪ Poriyal aridhal - Inspection 
▪ Pulanal aridhal - Palpation 
▪ Vinaathal  - Questionaries 
Poriyal aridhal and Pulanal aridhal means examining the patient’s Pori 
and Pulan with that of physician’s Pori and Pulan. Vinaathal is a method of 
enquiring about the details of the patient’s 
 
problem from his own words or from his parents or attenders who are 
taking care of the patient, when the patient is not able to speak (or) if the 
patient is a child.  
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ENVAGAI THERVUGAL (Eight tools of examination) are:  
 
 
Naadi (Pulse): 
In Kudiveri noi, the following types of Naadi could be felt.   
They were,  
a) Pithavaatham  
b) Vaathakabam  
c) Pithakabam  
Sparism(Touch) : Dry skin may be occur.  
Naa(tounge) : Abnormality of tongue like pale/ yellowish tongue may 
be noted 
Niram(Colour) : No abnormalities were observed.  
Mozhi(Speech) : Slurred speech in chronic case.  
Vizhi(Sight)  : Yellowish/ red eyes may be noted.  
Malam(Feces) : Diarrhea was reported in some cases.  
Moothiram(Urine) : Collection of urine for the determination of 
Neerkkuriand Neikkuri, is an important diagnostic method  
a) Neerkkuri  
Prior to the day of urine examination, the patient is instructed to take a 
balanced diet. The patient should have good sleep. After waking up in the 
morning, the first urine voided is collected in a clear wide mouthed glass 
container and is subjected to analysis of “Neerkkuri” within one and a half an 
hour. In Kudiveri noipatients, straw colored urine was noticed. 
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b)Neikkuri : 
 
The collected specimen (Urine) is kept open in a glass dish or china 
clay container. It is to be examined under direct sunlight, without any shaking 
of the vessel.Then add one drop of gingelly oil without disturbing the urinary 
specimen and the neikkuri was noted in direct sunlight and conclude the 
diagnosis as follows,   
 
Character of Vathaneer 
  When the oil drop spreads like a snake, it is called “Vaatha 
neer”  
 
Character of Pithaneer 
When the oil drop spreads like a ring, it is called “Pitha neer” 
 
Character of Kabaneer 
 When the oil drop appears like a pearl, it is called “Kaba neer”  
 
Character of Thonthaneer Snake in the ring, ring in the snake, snake in 
the pearl and ring in the pearl are the characters of Thontha neer. In Kudiveri, 
the Neikkuri was Vaatha neer, Pitha neer and Kaba neer.  
 
LINE OF TREATMENT  
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  Thiruvalluvar says in “Thirukkural” about physician’s duty to study 
the disease, study the cause, seek subsiding ways and do what is proper and 
effective.  
 
 
 
In Siddha system of medicine, the main aim of the treatment is to cure 
illness of body and mind. Treatment is not only for perfect healing but also for 
prevention and rejuvenation 
. 
❖ 
❖  
 Internal Medicine: Inji choornam 2gm, two times a day with warm water.  
 
Anubanam: 
 
   
  
Pathiyam (Dietary Regimen):            
 
 In mild conditions of the disease, salt and tamarind can be taken in little 
quantities. When the condition is severe, tamarind should be avoided and salt must be 
consumed after frying  
 
“
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MODERN ASPECTS 
 
ALCOHOLISM:  
Alcoholism is a broad term for problems with alcohol and is generally 
used to mean compulsive and uncontrolled consumption of alcoholic 
beverages, usually to the detriment of the drinker's health, personal 
relationships, and social standing. Alcohol misuse has the potential to damage 
almost every organ in the body, including the brain. The cumulative toxic 
effects of chronic alcohol abuse can cause both medical and psychiatric 
problems. Long-term consumption of alcohol in large quantities induces a 
number of disorders, e.g. fatty liver, alcoholic hepatitis, hepatocirrhosis, 
gastrointestinal disorder, chronic pancreatitis, peripheral nerve disorder, 
irregular heartbeat, hypertension and hematopoiesis disorder. Long-term 
alcohol consumption also causes phrenopathy and social effects, such as 
violent crimes and traffic accidents.  
 
Epidemiology: 
Substance use disorders are a major public health problem facing many 
countries. The most common substance of abuse/dependence in patients 
presenting for treatment is alcohol. In the United Kingdom, the number of 
'dependent drinkers' was calculated as over 2.8 million in 2001. About 12% of 
American adults have had an alcohol dependence problem at some time in 
their life. The World Health Organization estimates that about 140 million 
people throughout the world suffer from alcohol dependence. In the United 
States and Western Europe, 10 to 20 percent of men and 5 to 10 percent of 
women at some point in their lives will meet criteria for alcoholism.  Within 
the medical and scientific communities, there is broad consensus regarding 
alcoholism as a disease state.  Alcoholism has a higher prevalence among 
men, though in recent decades, the proportion of female alcoholics has 
increased. Current evidence indicates that in both men and women, alcoholism 
is 50–60 percent genetically determined, leaving 40–50 percent for 
environmental influences. Most alcoholics develop alcoholism during 
adolescence or young adulthood.  
Predisposing factor: 
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The biological mechanisms that cause alcoholism are not well 
understood.  
➢ Social environment  
➢ Stress  
➢ Mental health 
➢ Family history  
➢ Age   
➢ Ethnic group  
➢ Gender Signs and symptoms   
 
Early signs: 
The risk of alcohol dependence begins at low levels of drinking and 
increases directly with both the volume of alcohol consumed and a pattern of 
occasionally drinking larger amounts. Young adults are particularly at risk.   
 
Long-term misuse: 
Some of the possible long-term effects of ethanol an individual may 
develop tolerance to alcohol and withdrawal symptoms. Additionally, in 
pregnant women, alcohol can cause fetal alcohol syndrome. Alcoholism is 
characterized by an increased tolerance and physical dependence on alcohol, 
affecting an individual's ability to control alcohol consumption safely. These 
characteristics are believed to play a role in impeding an alcoholic's ability to 
stop drinking. Alcoholism can have adverse effects on mental health, causing 
psychiatric disorders and increasing the risk of suicide. The onset of 
depression is a common symptom.  
 
Physical: 
Long-term alcohol abuse can cause a number of physical symptoms including, 
▪ Cirrhosis of the liver, 
▪ Pancreatitis,  
▪ Epilepsy   
▪ Polyneuropathy,   
▪ Alcoholic dementia,   
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▪ Heart disease,  
▪ Nutritional deficiencies 
▪ Peptic ulcers  
▪ Sexual dysfunction  
Other physical effects include an increased risk of developing 
cardiovascular disease, malabsorption, alcoholic liver disease, and cancer. 
Damage to the central nervous system and peripheral nervous system can 
occur from sustained alcohol consumption. A wide range of immunologic 
defects can result and there may be a generalized skeletal fragility, in addition 
to a recognized tendency to accidental injury, resulting a propensity to bone 
fractures.  
 
Psychiatric: 
Long-term misuse of alcohol can cause a wide range of mental health 
problems. Severe cognitive problems are common; approximately 10 percent 
of all dementia cases are related to alcohol consumption, making it the second 
leading cause of dementia. Excessive alcohol use causes damage to brain 
function, and psychological health can be increasingly affected over time. 
Social skills are significantly impaired in people suffering from alcoholism 
due to the neurotoxic effects of alcohol on the brain, especially the prefrontal 
cortex area of the brain. The social skills that are impaired by alcohol abuse 
include impairments in perceiving facial emotions, prosody perception 
problems and theory of mind deficits; the ability to understand humor is also 
impaired in alcohol abusers. The most prevalent psychiatric symptoms are 
anxiety and depression disorders. Psychiatric symptoms usually initially 
worsen during alcohol withdrawal, but typically improve or disappear with 
continued abstinence.  
 
Social effects: 
The social problems arising from alcoholism are serious, caused by the 
pathological changes in the brain and the intoxicating effects of alcohol. 
Alcohol abuse is associated with an increased risk of committing criminal 
offences, including child abuse, domestic violence, rape, burglary and assault. 
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Alcoholism is associated with loss of employment, which can lead to financial 
problems. Drinking at inappropriate times and behavior caused by reduced 
judgment, can lead to legal consequences, such as criminal charges for drunk 
driving or public disorder, or civil penalties for tortious behavior, and may 
lead to a criminal sentence.  An alcoholic's behavior and mental impairment 
while drunk, can profoundly affect those surrounding them and lead to 
isolation from family and friends. This isolation can lead to marital conflict 
and divorce or contribute to domestic violence. Alcoholism can also lead to 
child neglect, with subsequent lasting damage to the emotional development 
of the alcoholic's children. For this reason, children of alcoholic parents can 
develop a number of emotional problems.  
 
Alcohol withdrawal:  
Alcohol withdrawal syndrome consists of unpleasant physical and 
mental symptoms following the cessation of alcohol consumption.  Repeated 
withdrawal episodes may contribute to the development of alcohol 
dependence and to the negative health consequences of drinking. The 
withdrawal syndrome is largely due to the central nervous system being in a 
hyper-excitable state. The severity of the alcohol withdrawal syndrome can 
vary from mild symptoms such as mild sleep disturbances and mild anxiety to 
very severe and life threatening including delirium, particularly visual 
hallucinations in severe cases and convulsions.  
➢ Alcoholic hallucinosis   
➢ Anorexia   
➢ Agitation  
➢ Anxiety and panic attacks  
➢ Catatonia   
➢ Confusion   
➢ Delirium tremens   
➢ Depersonalization   
➢ Depression   
➢ Derealization   
➢ Diaphoresis   
➢ Diarrhoea   
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➢ Euphoria   
➢ Fear   
➢ Gastrointestinal upset  
➢ Hallucinations   
➢ Headache   
➢ Hypertension   
➢ Hyperthermia (fever)   
➢ Insomnia   
➢ Irritability   
➢ Migraines   
➢ Nausea and vomiting   
➢ Palpitations   
➢ Psychosis   
➢ Rebound REM sleep   
➢ Restlessness   
➢ Seizures and death   
➢ Tachycardia   
➢ Tremors   
➢ Weakness   
Kindling: 
Kindling is the phenomenon where repeated alcohol detoxifications 
lead to an increased severity of the withdrawal syndrome. Those experiencing 
previous detoxification are more likely to have more medically complicated 
alcohol withdrawal symptoms. Kindling can cause complications and may 
increase the risk of relapse, alcohol-related brain damage and cognitive 
deficits. Chronic alcohol misuse and kindling via multiple alcohol withdrawals 
may lead to permanent alterations in the GABA receptors. The mechanism 
behind kindling is sensitization of some neuronal systems and desensitization 
of other neuronal systems which leads to increasingly gross neurochemical 
imbalances. This in turn leads to more profound withdrawal symptoms 
including anxiety, convulsions and neurotoxicity.   
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Binge drinking is associated with increased impulsivity, impairments 
in spatial working memory and impaired emotional learning. These adverse 
effects are believed to be due to the neurotoxic effects of repeated withdrawal 
from alcohol on aberrant neuronal plasticity and cortical damage. Repeated 
periods of acute intoxication followed by acute detoxification has profound 
effects on the brain and is associated with an increased risk of seizures as well 
as cognitive deficits. The effects on the brain are similar to those seen in 
alcoholics who have been detoxified multiple times but not as severe as in 
alcoholics who have no history of prior detox. Thus, the acute withdrawal 
syndrome appears to be the most important factor in causing damage or 
impairment to brain function. The brain regions most sensitive to harm from 
binge drinking are the amygdala and prefrontal cortex.  
Alcoholics who have had two or more alcohol withdrawals show more 
frontal lobe cognitive dysfunction than alcoholics who have experienced one 
or no prior withdrawals. Kindling of neurons is the proposed cause of 
withdrawal related cognitive damage. Kindling from multiple withdrawals 
leads to accumulating neuroadaptation changes. Kindling may also be the 
reason for cognitive damage seen in binge drinkers.  
 
Protracted withdrawal: 
A protracted alcohol withdrawal syndrome occurs in many alcoholics 
where withdrawal symptoms continue beyond the acute withdrawal stage but 
usually at a subacute level of intensity and gradually decreasing with severity 
over time. This syndrome is also sometimes referred to as the post-acute 
withdrawal syndrome. Some withdrawal symptoms can linger for at least a 
year after discontinuation of alcohol. Symptoms can include a craving for 
alcohol, inability to feel pleasure from normally pleasurable things (also 
known as anhedonia), clouding of sensorium, disorientation, nausea and 
vomiting or headache. Insomnia is also a common protracted withdrawal 
symptom which persists after the acute withdrawal phase of alcohol. Insomnia 
has also been found to influence relapse rate.  
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Insomnia can be difficult to treat in alcoholics because many of the 
traditional sleep aids (e.g. benzodiazepine receptor agonists and barbiturate 
receptor agonists) work via a GABA receptor mechanism and are cross 
tolerant with alcohol.  
 
Alcoholic liver disease: 
The causal association between alcohol intake and the development of 
alcoholic liver disease has been well demonstrated. It is presumed, therefore, 
the other factors, such as gender, genetic background and additional 
environmental influences, particularly chronic viral infection, play a role in the 
genesis of alcoholic liver disease. The spectrum of liver damage caused by 
alcohol is not uniform. For descriptive purposes, three main histological stages 
are described as if they constitute separate and definitive lesions: steatosis, 
acute alcoholic hepatitis and cirrhosis. In reality, these entities overlap, and it 
is difficult to find them isolated in their pure histopathological form. Steatosis 
is a predictable histological abnormality which develops in many heavy 
drinkers. It results from the redox imbalance generated by the metabolism of 
ethanol to acetate. Alcoholic steatosis completely reverses within several 
weeks of discontinuation of alcohol intake. Acute alcoholic hepatitis is 
characterized by hepatocellular injury with associated inflammation and 
fibrosis.   
Hepatitis usually improves with abstinence. When alcohol use 
continues unabated, inflammation triggers fibro genesis and over time, 
collagen is deposited in a characteristic perivenular and peri cellular 
distribution. Approximately 40% of patients with this lesion (zone 3 fibrosis 
extending in a lattice-like peri-hepatocyte network) will develop cirrhosis 
within 5 years. Severe acute alcoholic hepatitis has a poor outcome with 
standard supportive management. For example, the mortality rate of patients 
with severe alcoholic hepatitis in two prospective studies was 35% and 46%, 
respectively. The addition of acute renal failure worsens the prognosis further.  
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Alcoholism stages:  
 
➢ Pre-alcoholic phase, which includes social drinking when drinkers 
often start to develop a tolerance for alcohol and drink to relieve stress 
or feel better 
➢ Prodromal phase, also considered the early-alcoholic stage where 
blackouts begin to occur, the drinker begins to drink alone and in 
secret and thinks about alcohol frequently while their alcohol 
tolerance continues to grow  
➢ Crucial phase characterized by a spiral of out-of-control drinking at 
inappropriate times and problems with daily life and relationships as 
well as physical changes to the brain and body  
➢ Chronic phase which includes daily drinking, drinking as the main 
focus of life, health problems cropping up, cravings and withdrawal 
symptoms, and physical and mental long-term alcohol abuse issues  
Pathophysiology: 
Chronic use of alcohol leads to changes in brain chemistry especially 
in the GABAergic system. Various adaptations occur such as changes in gene 
expression and down regulation of GABA receptors. During acute alcohol 
withdrawal, changes also occur such as upregulation of alpha 4 containing 
GABA receptors and down regulation of alpha1 and alpha3 containing GABA 
receptors. Neurochemical changes occurring during alcohol withdrawal can be 
minimized with drugs which are used for acute detoxification. With abstinence 
from alcohol and cross tolerant drugs these changes in neurochemistry 
gradually return towards normal.  Adaptations to the NMDA system also 
occur as a result of repeated alcohol intoxication and are involved in the 
hyper-excitability of the central nervous system during the alcohol withdrawal 
syndrome. Homocysteine levels which are elevated during chronic drinking 
increase even further during the withdrawal state and may result in excito-
neurotoxicity. Alterations in ECG, in particular an increase in QT interval, and 
EEG abnormalities including may occur during early withdrawal. Dysfunction 
of the hypothalamic–pituitary–adrenal axis and increased release of 
corticotropin-releasing hormone occur during both acute as well as protracted 
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abstinence from alcohol and contribute to both acute and protracted 
withdrawal symptoms. Anhedonia/dysphoria symptoms, which can persist as 
part of a protracted withdrawal may be due to dopamine under activity.  
 
Diagnosis: 
Identifying alcoholism is difficult for the individual afflicted because 
of the social stigma associated with the disease that causes people with 
alcoholism to avoid diagnosis and treatment for fear of shame or social 
consequences. The evaluation responses to a group of standardized 
questioning is a common method for diagnosing alcoholism. These can be 
used to identify harmful drinking patterns, including alcoholism. In general, 
problem drinking is considered alcoholism when the person continues to drink 
despite experiencing social or health problems caused by drinking.  
 
International Classification of Diseases (ICD-10): 
International Classification of Diseases and Health Related Problems 
(ICD10;1992) defines the (alcohol) dependence syndrome  as “a cluster of 
behavioral, cognitive and physiological phenomena that develop after repeated 
(alcohol) use and that typically include a strong desire to take (alcohol), 
difficulties in controlling its use, persisting in its use despite harmful 
consequences, a higher priority given to drug use than to other activities and 
obligations, increased tolerance, and sometimes a physical withdrawal state .  
 
American Medical Association diagnosis:   
The American Medical Association supports a dual classification of 
alcoholism to include both physical and mental components.  
 
 DSM diagnosis: 
Under the DSM's new definition of Alcoholism about 37 percent of 
college students may meet the criteria. Doctors are hoping that this new 
definition of the term will help catch severe cases of alcoholism early, instead 
of when the problem is full-blown. The DSM-IV diagnosis of alcohol 
dependence represents one approach to the definition of alcoholism. In part 
this is to assist in the development of research protocols in which findings can 
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be compared to one another. According to the DSM-IV, an alcohol 
dependence diagnosis is: maladaptive alcohol use with clinically significant 
impairment as manifested by at least three of the following within any one-
year period: tolerance; withdrawal; taken in greater amounts or over longer 
time course than intended; desire or unsuccessful attempts to cut down or 
control use; great deal of time spent obtaining, using, or recovering from use; 
social, occupational, or recreational activities given up or reduced; continued 
use despite knowledge of physical or psychological sequelae.  
 
Screening: 
Several tools may be used to detect a loss of control of alcohol use. 
These tools are mostly self-reports in questionnaire form. Another common 
theme is a score or tally that sums up the general severity of alcohol use. The 
CAGE questionnaire, named for its four questions, is one such example that 
may be used to screen patients quickly in a doctor's office.   
Two yes responses indicate that the respondent should be investigated 
further. The questionnaire asks the following questions:  
 1. Have you ever felt you needed to Cut down on your drinking?   
2. Have people Annoyed you by criticizing your drinking?   
3. Have you ever felt Guilty about drinking?  
4. Have you ever felt you needed a drink first thing in the morning 
(Eye-opener) to steady your nerves or to get rid of a hangover?   
The CAGE questionnaire has demonstrated a high effectiveness in 
detecting alcohol-related problems; however, it has limitations in people with 
less severe alcohol related problems, white women and college students. Other 
tests are sometimes used for the detection of alcohol dependence, such as the 
Alcohol Dependence Data Questionnaire, which is a more sensitive diagnostic 
test than the CAGE questionnaire. It helps distinguish a diagnosis of alcohol 
dependence from one of heavy alcohol use. The Michigan Alcohol Screening. 
Test (MAST) is a screening tool for alcoholism widely used by courts to 
determine the appropriate sentencing for people convicted of alcohol-related 
offenses, driving under the influence being the most common. The Alcohol 
Use Disorders Identification Test (AUDIT), a screening questionnaire 
developed by the World Health Organization, is unique in that it has been 
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validated in six countries and is used internationally. Like the CAGE 
questionnaire, it uses a simple set of questions – a high score earning a deeper 
investigation. The Paddington Alcohol Test (PAT) was designed to screen for 
alcohol-related problems amongst those attending Accident and Emergency 
departments. It concords well with the AUDIT questionnaire but is 
administered in a fifth of the time.  
 
Urine and blood tests: 
There are reliable tests for the actual use of alcohol, one common test 
being that of blood alcohol content (BAC). These tests do not differentiate 
alcoholics from non-alcoholics; 
 however, long-term heavy drinking does have a few recognizable 
effects on the body, including:   
❖ Macrocytosis (enlarged MCV)   
❖ Elevated GGT   
❖ Moderate elevation of AST and ALT and an AST: ALT ratio of 
2:1   
❖ High carbohydrate deficient transferrin (CDT) However, none 
of these blood tests for biological markers is as sensitive as 
screening questionnaires.  
Treatment 
 Benzodiazepines are effective for the management of symptoms as 
well as the prevention of seizures. Treatment of alcohol withdrawal syndrome 
can be managed with various pharmaceutical medications including 
barbiturates and clonidine. Certain vitamins are also an important part of the 
management of alcohol withdrawal syndrome. 
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DRUG   REVIEW 
 
INJI 
 
Botanical name   : Zingiber officinale, 
English name     : Ginger 
Family     :  Zingiberaceae 
 
Organoleptic characters:  
 
Taste         :  Kaarppu 
Potency    :  Veppam  
Division   :  Kaarppu 
 
        
Chemical constituents:  
 
  Camphene, Phellandrene, Zingiberene, Cineol, Borneol 
 
Actions:  
 
Aromatic, Carminative, Stimulant to GI Tract, Stomachic, 
Digestive, Sialagogue 
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Ealam 
 
Botanical name   : Electtaria cardamomum 
English name    : Cardamom seeds 
Family     :  Zingiberaceae 
 
Organoleptic characters:  
 
Taste         :  Kaarppu 
Potency    :  Veppam  
Division   :  Kaarppu 
 
Chemical constituents:  
 
1,8- cineole, α-terpinyl acetate, Limonene, sabinene, α-
terpineol, α-pinene, linalool, 4,8,12- trimethyl, 4,8- dimethyl, 1,2,7,11- 
tridecatetraene  
 [Ref. Book: Medicinal plants-Edward Jarald] 
 
Actions:  
 
Anti-inflammatory, Analgesic, Anti spasmodic ,Anti-oxidant, 
Cholagogue   
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CHUKKU 
 
Botanical name   : Zingiber officinale, 
English name    : Dried Ginger 
Family     :  Zingiberaceae 
 
Organoleptic characters:  
 
Taste         :  Kaarppu 
Potency    :  Veppam  
Division   :  Kaarppu 
 
 
Chemical constituents: 
 
 Camphene, Phellandrene, Zingiberene, Cineol, Borneol 
 
Actions:  
 
Aromatic, Carminative, Stimulant to GI Tract, Stomachic, 
Digestive, Sialagogue 
 
 
 
 
 
 
34 
 
 
MILAKU 
 
Botanical name   : Piper nigrum 
English name    : Black Pepper 
Family     :  Piperaceae 
 
Organoleptic characters:  
 
Taste         :  Kaarppu 
Potency    :  Veppam  
Division   :  Kaarppu 
 
Chemical constituents:  
 
Piperine or Pipirine  
Piperidine or Piperidin Chavicin  
 
Actions:  
  
Acrid, Pungent, Carminative, Antiperiodic, Antipyretic, 
Aphrodisiac 
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THIPPILI 
 
Botanical name   : Piper longum 
English name    : Long pepper 
Family     :  Piperaceae 
 
Organoleptic characters:  
 
Taste         :  Inippu 
Potency    :  Veppam  
Division   :  Inippu  
 
 
Chemical constituents:  
 
Piperine,Fatty oil, Resin, Volatile oil 
 
Actions:  
 
Carminative, Aphrodisiac, Diuretic, Vermifuge, Emmenagogue 
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KIRAMBU 
 
Botanical name   : Syzygium aromaticum 
English name    : Cloves 
Family     :  Myrtaceae 
 
Organoleptic characters: 
 
Taste         :  Kaarppu 
Potency    :  Veppam  
Division   :  Kaarppu 
 
Chemical constituents:  
volatile oil, .β-caryophyllene, Eugenol acetate, α-humulence, δ-
decalactone, fenchone, hexanal, hexanone, methyl palmitate,  palustrol, 
prophyl benzoate. Aceto phenone, benzyl salicylate, α-cardinol.  
[Ref. Book: Medicinal plants-Edward Jerald]  
 
Actions:  
Carminative, Aphrodisiac, Stimulent, Antispasmotic, 
Rebufucient, Stomatic, Local Anaesthetic, Anti Septic,Anti 
carcinogenic, Anti thrombotic, Anti oxidative 
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OMAM  
 
Botanical name   : Carum copticum 
English name    : The Bishops weed 
Family     :  Apiaceae 
 
Organoleptic characters:  
 
Taste         :  Kaarppu 
Potency    :  Veppam  
Division   :  Kaarppu 
 
 
Chemical constituents:  
 
Earoptin, Cumene, Thymene, Aromatic, Volatile Essential Oil 
 
Actions:  
 
Diffusible, Stimulent, Stomachic ,Carminative, Tonic, 
Aromatic ,Pungent Antispasmodic, Anthelmentic    
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VALUZHUVAI 
 
Botanical name   : Celastrus paniculatus 
English name    : Climbing staff plant 
Family     :  Celastraceae 
 
Organoleptic characters:  
 
Taste         :  Kaippu 
Potency    :  Veppam  
Division   :  Kaarppu 
 
 
Chemical constituents:  
 
 Alkaloids, Glucosides, Tannin, Coloring Matters 
 
Actions:  
 
Rubefacient, Stimulant, Nervine, Stimulate, Intellect And 
Sharpen Memory 
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SATHIKKAI 
 
Botanical name   : Myristica fregrans 
English name      : Nut meg 
Family     :  Myrtaceae 
 
Organoleptic characters:  
 
Taste         :  Thuvarppu , Kaarppu 
Potency    :  Veppam  
Division   :  Kaarppu 
       
 
Chemical constituents: 
 
 Volatile oil, Proteids, Resin, Myristin, Myristic Acid, 
Myristicene, Myristocol 
 
Actions: 
 
Aromatic, Stimulant, Carminative, Narcotic, Rubefucient, 
Aperient, Aphrodiasic Intoxicating, Tonic, Digestive, Gastric Tonic 
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YANAI THIPPILI 
 
Botanical name   : Scidapsus officinale 
English name      : Cardamom seeds 
Family     :  Araceae 
 
Organoleptic characters:  
 
Taste         :  Kaarppu 
Potency    :  Veppam  
Division   :  Kaarppu 
 
       
 
Chemical constituents:  
 
  Alkaloids, gum, ash 
Actions:  
 
Carminative, Stimulant, Tonic, Anthelmintic, Sudorific   
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SEERAGAM  
 
Botanical name   : Cuminum cyminum 
English name     : Cumin seeds 
Family     :  Apiaceae 
 
Organoleptic characters:  
 
Taste         :  Kaarppu , Inippu 
Potency    :  Thatpam  
Division   :  Inippu 
 
   
 
Chemical constituents:  
 
Cuminaldehyde, cuminin,1,3- β menthadien-7-al, 1,4-β 
menthadien-7-al, δ-terpinene, βpinene,7-1(O- β- D-galalacturonide), 
3,5- dihydroxy flavones, glycosides of luteolin and apigenin. [Ref. 
Book: Medicinal plants-Edward Jarald] 
 
Actions:  
 
Carminative, Aromatic, Stomachic, Stimulant, Astringent, 
Digestive, Diuretic Emmenagogue 
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ATHIMATHURAM 
 
Botanical name   : Glycyrrhiza glabra Linn 
English name   : Liquorice 
Family   : Fabaceae 
 
Organoleptic characters:  
Taste         :Inippu 
Potency   :Thatpam  
Division   :Inippu 
 
 
 
Chemical constituents: 
 
Glycyrrhizin, glycyrrhizic acid, Glabraninis A& B, 
Isoglabrolide, deoxoglabrolide, glabrolide, glycyrrhetol, Liquoric, 
Liquiritic, glycyrrhetic, glabranine, pinocembrin, prunetin, 
glucoliquitin apioside, prenyllico flavones A, echinatin.                                         
  [Ref. Book: Medicinal plants-Edward Jarald] 
 
Actions:  
Anti-hepatotoxic activity, Anti diuretic activity, inhibit tumor 
producing activity,Anti-viral  
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KUROSANI OMAM 
 
Botanical name   : Hyoscyamus niger Linn 
English name      : Henbane seeds 
Family     :  Solanaceae 
 
Organoleptic characters:  
 
Taste         :  Kaarppu , Sirukaippu 
Potency    :  Veppam  
Division   :  Kaarppu 
 
      
 
Chemical constituents:  
 
 Hyoscyamine, Hyoscine, Hyosciprin, scopolamine, cholin, 
fattyacid, albumin potassium nitrate 
 
Actions:  
 
Intoxicating, Narcotic, Anodyne, Digestive, Astrigent, 
Anthelmentic, Sedative 
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AMUKKARA 
 
Botanical name   : Withania somnifera 
English name      : Withania somnifera 
Family     :  Solanaceae 
 
Organoleptic characters:  
 
Taste         :  Kaippu 
Potency    :  Veppam  
Division   :  Kaarppu 
 
Chemical constituents:  
 
Somniferin, Phytosterol, Ipuranol, Mixture, Saturated & Un 
Saturated Acids 
 
Actions:  
 
   Tonic, Alternative, Astrigents, Aphrodisiac, Nervine, Sedative 
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KASAKASAA  
  
Botanical name   : Papaver somniferum.Linn 
English name     : Opium poppy 
Family     :  Papaveraceae 
 
Organoleptic characters:  
 
Taste         :  Inippu 
Potency    :  Veppam  
Division   :  Inippu 
 
 
Chemical constituents:  
 
Morphine, Codeine, Narcotine  
 
Actions:  
 
   Demulcent, Nutritive, Mild Astrigent 
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ELAVANGA PATHIRI 
 
Botanical name   : Cinnamomum tamal Buch. Hum 
English name      : Cassia cinnamon 
Family     :  Lauraceae 
 
Organoleptic characters:  
 
Taste         :  Kaarppu 
Potency    :  Veppam  
Division   :  Kaarppu 
 
 
Chemical constituents:  
 
Essential Oil, Eugenol, Terpene, Cinnamic, Aldehyde  
 
Actions:  
 
Carminative, stimulant, diuretic, diaphoretic, dedobstruent, 
lactagogue 
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MODI (THIPPILI MOOLAM) 
  
Botanical name   : Piper longum 
English name    : Long pepper 
Family     :  Piperaceae 
 
Organoleptic characters:  
 
Taste         :  Kaarppu 
Potency    :  Veppam  
Division   :  Kaarppu 
 
 
Chemical constituents: 
 
Piperine, Fatty oil, Resin, Volatile oil 
 
Actions:  
Carminative, Aphrodisiac, Diuretic, Vermifuge, Emmenagogue  
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KOTHAMALLI 
 
Botanical name   :  Coriandrum sativm Linn 
English name  : Coriander seeds 
Family   : Apiaceae  
 
Organoleptic characters: 
 
Taste      : Kaarppu 
Potency  : Seetha veepam 
Division  : Kaarppu 
 
        
 
Chemical constituents:  
 
Essential Oil, Linolool, Monoterpene Hydrocarbous ,  Borneol, 
Citrovellol, Camphor, Geraniol, Geranyl Acetalis, Heterocyclic 
Components, Coriandrin, Dihyhy Coriandrine, Coriandrones A-E, 
Flavonoids, Neochidilide, Phenolic Acids, Sterols. 
[Ref. Book: Medicinal plants-Edward Jarald]  
 
Actions: 
 
Strong Antifungitoxity, Stomachic Spasmolytic, Carminative, 
Hydolipidemic, Insulin Releasing, Microbicidal  
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PERITCHAI 
 
Botanical name   : Phonex dactilifera Linn 
English name    : Date palm 
Family     :  Aracaceae 
 
Organoleptic characters:  
Taste         :  Inippu 
Potency    :  Veppam  
Division   :  Kaarppu 
 
 
        
Chemical constituents:  
 
Iron in an assimilable form, Tannin, Mucilage, Insoluble Matter 
and Lime 
 
Actions:  
 
Expectorent, Aphrodisiac, Tonic, Demulcent, Lavative, Diuretc 
And Highly Saccharine 
 
 
 
 
 
 
 
50 
 
MUNTHIRIKAI 
 
Botanical name   : Vitis vinifera 
English name     : Grapes 
Family     :  Vitaceae 
 
Organoleptic characters:  
 
Taste         :  Inippu 
Potency    :  Thatpam  
Division   :  Inippu 
 
It cures stomach disturbance, dry cough, fever, jaundice, 
wheezing, thrust, also prevent form heart diseases 
 
Chemical constituents:  
 
Tartaric Acid Citric Acid Racemic Acid and Malic Acid 
Chlorides of Potassium and Sodium, Potassium Sulphate, Alum, 
Magnesia, Iron, Ozotised Matters  
 
Actions:  
 
Demulcent, Laxatives, Refrigerant, Stomachic, Diuretic, 
Expectorant, Nutritious, Blood Purifier 
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SUGAR 
 
Botanical name   : Saccharum officinarum.Linn 
English name      : Sugarcane 
Family     :  Poaceae 
 
Organoleptic characters:  
 
Taste         :  Inippu 
Potency    :  Seetham 
Division   :  Inippu 
 
       
 
Chemical constituents:  
 
 Trolox, Beta-Carotene, Linoleic Acid, Apigenin, Catechin, 
Caffeic, Ferulic And Chlorogenic Acids 
 
Actions:  
   Demulcent, Antiseptic, Cooling, Laxative, Diuretic, Nutrient,  
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MATERIALS AND METHODS 
 
a) STANDARD OPERATING PROCEDURES OF INJI CHOORANAM 
Source of trial medicine: 
           The raw drugs for the preparation of Inji Chooranam will be purchased from a 
well reputed country shop and the purchased drugs will be authenticated by the 
competent authority (Medicinal botany dept., NIS). After that the raw drugs will be 
purified separately then the trial drugs will be prepared in Gunapadam Laboratory of 
National Institute of Siddha. 
Raw drugs Identification and authentication: 
These ingredients were identified and were authenticated by Dr.D.Aravind 
M.Sc, Asst Prof, Medicinal Botanist at NIS, Tambaram sanatorium, Chennai.(Drug 
Authentication Number : Nismb2962017) 
Ingredients of Inji  Choornam: 
Inji   (Zingiber officinale)  - 350gm (10 palam) 
Ealam   (Electtaria cardamomum) - 8.75gm (1/4 palam) 
Chukku  (Zingiber officinale)  - 8.75gm (1/4 palam) 
Milaku   (Piper nigrum)  - 8.75gm (1/4 palam) 
Thippili  (Piper longum)  - 8.75gm (1/4 palam) 
Kirambu  (Syzygium aromaticum) - 8.75gm (1/4 palam) 
Omam   (Carum copticum)   -8.75gm (1/4 palam) 
Valuzhuvai  (Celastrus paniculatus)  -8.75gm (1/4 palam) 
Sathikkai  (Myristica fregrans)   -8.75gm (1/4 palam) 
Yanai Thippili  (Scidapsus officinale)   - 8.75gm (1/4 palam) 
Seeragam  (Cuminum cyminum)   - 8.75gm (1/4 palam) 
Athimaduram  (Glycyrrhiza glabra)   - 8.75gm (1/4 palam) 
Kurosani Omam (Hyoscyamus niger)   - 8.75gm (1/4 palam) 
Amukara  (Withania somnifera)   - 8.75gm (1/4 palam) 
KasaKasaa  (Papaver somniferum)  - 8.75gm (1/4 palam) 
Elavanga pathiri (Cinnamomum tamal)   - 8.75gm (1/4 palam) 
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Modi   (Piper longum)  - 8.75gm (1/4 palam) 
Kothamalli  (Coriandrum sativum) - 8.75gm (1/4 palam) 
Peritchai  (Phonex dactilifera)   - 8.75gm (1/4 palam) 
Munthirikai  (Vitis vinifera)   - 8.75gm (1/4 palam) 
Sarkarai  (Saccharum officinarum) -350gm (10 palam)  
 
 
METHOD OF PURIFICATION: 
 
 Inji: 
Cleaned & remove outer layer of skin 
 
Ealam: 
Dried in sun shade and fried. 
 
Chukku: 
Soaked   in lime stone water for a period of   time and 
dried it in sun shade then peel off   the outer layer.   
 
Milaku: 
Soaked   in butter milk for a period of 1 saamam (3 
hours) then allowed it to dry.  
Thippili: 
Soaked in Lime juice for a period of time   then allow   
it to dry 
 
Kirambu: 
Dried in sun shade and fried 
 
Omam : 
   Drenched in limestone water and dried. 
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 Valuzhuvai: 
Dried in sun shade and fried 
  
Sathikkai: 
Remove the outer cover, cut into small pieces and dried 
in sunshade 
 
Yanai Thippili: 
   Dried in sunshade. & fried. 
 
Seeragam:  
Dried in sunshade & fried. 
 
Athimathuram: 
Washed with water and outer layer is pealed, then cut 
into small pieces, finally dried, cut into small pieces and 
finally dried it. 
 
Kurosani Omam: 
Dried in sun shade and fried 
 
Amukara:  
Dried in sun shade and fried 
 
Elavanga pathiri: 
Dried in sun shade and fried 
 
Modi (Thippili Moolam):  
Dried in sun shade and fried 
 
Kothamalli:  
Process it in thula endhiram and dried in sun light. 
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Peritchai: 
   Removed the seed,dried sun shade 
 
Munthirikai:  Dried in sun shadeand fried 
 
Sugar:  
 Equal quantity. 
 
 
Raw drugs of Inji chooranam 
 
                            INJI               EALAM 
 
 
  
 
 
 
                    
 
 
 
 
 
 
 
CHUKKU             MILAKU 
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   THIPPILI          KIRAMBU 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   OMAM          VALUZHUVAI 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   SATHIKKAI             YANAI THIPPILI 
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SEERAGAM     ATHIMATHURAM 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
              KUROSANAI OMAM             AMUKKURA 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
       
  
KASAKASA     ELAVANGA PATHIRI
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MODI (THIPPILI MOOLAM)   KOTTHAMALLI 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
  PERITCHAI       MUNTHIRIGAI 
 
 
 
 
 
SARKKARAI 
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Method of preparation:  
                All the above ingredients are powdered separately. Mixed well together and 
prepared as choornam. 
 
Drug storage: 
 The trial drugs Inji Choornam (Internal) is stored in clean dry container. 
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BIO-CHEMICAL AND ELEMENTAL ANALYSIS 
 
Qualitative Analysis 
 
Sl. No EXPERIMENT OBSERVATION INFERENCE 
1 Appearance of the 
sample 
 
Brown in Colour  
 
2 Solubility:   
a.  A little of the sample 
is shaken well with 
distilled water.  
b. A little of the sample 
is Shaken well with con. 
Hcl Con. H2SO4. 
 
 
Completely soluble 
 
 
 
Completely soluble 
 
 
Absence of Silicate 
3 ACTION OF HEAT: 
A small amount of the 
sample is taken in a dry 
test tube and heated 
gently at first and then 
Strong.  
 
White fumes not evolved  
 
Brown fumes not evolved  
 
Absence of Carbonate.                          
 
 
Absence of Nitrate.  
 
4 FLAME  TEST:  
A small amount of the 
sample is made into a 
paste with con. Hcl in a 
watch glass and 
introduced into non-
luminous part of the 
Bunsen flame 
 
White flame  is appeared 
 
Absence of Copper. 
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5 ASH TEST:  
A filter paper is soaked 
into a mixture of sample 
and cobalt nitrate 
solution and introduced 
into the Bunsen flame 
and ignited. 
 
No Yellow colour flame. 
 
Absence of Sodium 
 
Preparation of The Extract 
 5 gm of Inji chooranam was weighed accurately and placed in a 250 ml clean 
beaker. Then 50 ml distilled water was added and dissolved well. Then it is boiled 
well for about 10 minutes. It was cooled and filtered in a 100 ml volumetric flask and 
then it was made up to 100 ml with distilled water. This fluid was taken for analysis. 
 
SL. 
NO. 
EXPERIMENT OBSERVATION INFERENCE 
TEST FOR ACID RADICALS 
1 Test for Sulphate:  
a. 2 ml of the above 
prepared extract is taken in 
a test tube to this added 
2ml of 4% ammonium 
oxalate solution.  
b. 2ml of the above 
prepared extract is added 
with 2 ml of dil-Hcl is 
added until the 
effervescence ceases off. 
Then 2ml of Barium 
chloride solution is added.  
 
Cloudy appearance 
present  
 
 
 
 
A white precipitate 
insoluble in con. Hcl is 
obtained  
 
 
 
 
 
Presence of Sulphate 
 
 
 
 
 
Sulphate is Confirmed 
2 Test for Chloride: 
 2 ml of the above prepared 
Extract is added with dil. 
HNO3 till the 
 
Cloudy appearance 
present (Mild trace 
element) 
 
Presence of Chloride. 
62 
 
effervescence ceases. Then 
2 ml of silver nitrate 
solution is added 
3 Test for Phosphate: 
 2 ml of the extract is 
treated with 2ml of 
ammonium molybdate 
solution and 2 ml of con. 
HNO3 
 
No Cloudy yellow 
appearance 
 
Absence of  Phosphate 
4 Test for Carbonate:  
2m1 of the extract is 
treated with 2m1 
magnesium sulphate 
solution 
 
No cloudy appearance 
 
 
 
 
 
Absence of Carbonate. 
5 Test for Nitrate: 
 1gm of the substance is 
heated with copper turnings 
and concentrated H2SO4   
and viewed the test tube 
vertically down. 
 
Brown gas is not 
evolved 
 
Absence of Nitrate 
6 Test for Sulphide:  
1 gm of the substance is 
treated with 2m1 of con. 
Hcl 
 
 
No Rotten egg smelling 
gas evolved 
 
Absence of Sulphide 
7 Test for fluoride & 
oxalate: 
2 m1 of The Extract Is 
Added With 2m1of Acetic 
Acid and 2 m1 calcium 
Chloride solution and 
heated 
 
 
No Cloudy appearance 
 
 
Absence of Fluoride& 
Oxalate 
8 Test for Nitrite:     
3drops of extract is placed 
on a filter paper,on that 2 
 
No characteristic 
Changes. 
 
Absence of nitrite 
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drops of acetic Acid and 2 
drops of benzidine solution 
is placed.  
9 Test for Borate:     
 2 pinches of the substance 
are made into paste by 
using sulphuric acid and 
alcohol (95%) and 
introduced into the blue 
flame. 
  
Absence of borate 
 
           II. TEST FOR BASIC RADICALS 
1 Test for Lead:  
2 m1of the extract is added 
with 2m1of potassium 
iodide solution 
 
No Yellow precipitate is 
obtained 
 
Absence of Lead 
2 Test for Copper:  
a. One pinch of substance 
is made into paste with con. 
Hcl in a watch glass and  
introduced into the non-
luminous part of the flame.  
b. 2 ml of extract is added 
with excess of ammonia 
solution 
 
No Blue colour flame  
precipitate 
 
 
 
 
 
No Blue colour 
precipitate 
 
Absence of Copper.  
 
 
 
 
 
 
Absence of Copper 
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3 Test for Aluminium:  
Take the 2m1of the extract 
sodium hydroxide is added 
in drops to excess 
 
No characteristic 
changes 
 
Absence of Aluminium 
4 Test for Iron: 
(Ferrous)To the 2 ml of 
extract 2m1                                         
ammonium thiocyanate 
solutionand 2m1of con. 
HNO3 is added                                                             
 
Blood red colour 
Appearance
 
 
 
Presence of Iron. 
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Test For Zinc:      
To 2m1 of the extract 
sodium hydroxide solution 
is added in drops to excess 
 
White precipitate is not 
Formed 
 
Absence of Zinc 
6 Test For Calcium: 
2m1 of the extract is added 
with 2m1 of 4% 
ammonium oxalate 
Solution 
 
Cloudy appearance and 
white precipitate                       
is obtained  
 
Absence of Calcium. 
7 Test For Magnesium: 
To 2ml of extract sodium                                   
hydroxide solution is added 
in drops to excess.  
 
White precipitate is not 
obtained.  
 
 
Absence of Magnesium. 
8 Test For Ammonium:    
To 2ml of extract few ml of 
Nessler's reagent and 
excess of sodium hydroxide 
solution are added. 
 
No brown colour 
appeared 
 
Absence of Ammonium 
9 Test For Potassium:    
A pinch of substance is 
treated with 2ml of sodium 
nitrite solution and then 
treated with 2m1 of cobalt 
 
No Yellowish 
precipitate is obtained 
 
Absence of Potassium 
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nitrate in 30% glacial acetic 
acid 
10 Test For Mercury:     
2m1 of the extract is treated 
with 2ml of sodium 
hydroxide solution. 
 
 
 
No Yellow colour  
Flame appeared.  
 
Absence of Sodium 
11 Test For Mercury:   
2m1 of the extract is treated 
with 2ml of sodium 
hydroxide solution 
 
Yellow precipitate                           
is not obtained  
 
 
Absence of Mercury 
12 Test For Arsenic:    
2m1 of the extract is treated 
with 2m1 of sodium 
hydroxide solution. 
 
No brownish red 
Precipitate is obtained 
 
Absence of Arsenic 
III. MISCELLANEOUS 
1 Test for Starch:  
2ml of extract is treated 
with weak iodine solution. 
 
No blue colour 
developed 
 
Absence of Strarch 
2 Test For Reducing Sugar: 
5ml of Benedict's 
qualitative solution is taken 
in a test tube and allowed 
to boil for 2 minutes and 
added 8 to 10 drops of the 
extract and again boil it for   
2 minutes. The colour 
changes are noted 
 
No Brick red colour 
developed 
 
Absence of Reducing 
sugar 
3 Test For The Alkaloids:  
a. 2m1 of the extract is 
treated with 2ml of 
potassium Iodide solution.                        
 b. 2m1 of extract is treated 
with  2ml of picric acid. 
 c. 2m1 of the extract is 
 
 
Red colour developed  
 
 
 
 Trace Yellow colour 
 
 
Presence of Alkaloid.  
 
 
 
Trace of  Alkaloid present.  
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treated with 2ml of 
phosphotunstic acid.  
developed  
 
White precipitate 
developed 
 
 
Presence of Alkaloid.  
 
4 Test for Tannic Acid:    
2ml of extract is treated 
with 2ml of ferric chloride 
solution 
 
Black precipitate is 
obtained 
 
Presence of Tannic acid. 
5 Test for Unsaturated 
Compound:   
To the 2ml of extract 2ml 
ofPotassium Permanganate 
solution is added 
 
Potassium 
Permanganate is 
decolorized 
 
Presence of Unsaturated 
Compound. 
6 Test For Amino Acid:     
2 drops of the extract is 
placed on a filter paper and 
dried well and 2 ml of 
biuret reagent is added 
 
 
No Violet colour 
developed 
 
 
Absence of Amino acids. 
7 Test For type of 
Compound:    
2ml of the extract is treated 
with 2 ml of ferric chloride 
solution. 
 
 
Green colour developed  
 
 
 
No Red colour 
developed  
 
 
No Violet colour 
developed  
 
 
No blue colour 
developed 
 
 
Presence of oxy quinole 
epinephrine and pyro 
catechol.  
 
Anti pyrine, Aliphatic          
amino acids and Meconic 
acid are absent.  
 
Apomorphine, Salicylate 
and Resorcinol are absent.  
 
Morphine, Phenol cresol 
and hydro quinone are 
absent 
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RESULT:  
The Bio-chemical analysis of Inji chooranam had shown the presence of 
Sulphate, Chloride, Phosphate, Reducing Sugar, Iron, Tannic acid, oxy quinol 
epinephrine and pyro catechol, unsaturated compound and Alkaloids.  
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b) CLINICAL 
STUDY TYPE   :  An Open Clinical Trial. 
STUDY PLACE   : Ayothidoss Pandithar Hospital,  
   National Institute of Siddha, Chennai-47. 
STUDY PERIOD   : 18 months 
SAMPLE SIZE   : 30 patients. 
TRIAL DRUG: 
INTERNAL MEDICINE  :  Inji Chooranam 
(Reference: Agathiyar paripooranam 400, Page no 111 &112) 
DOSAGE     :   2gm, twice a day  
ADJUVANT     :   Warm water 
DURATION     :    45 days 
 
 
SUBJECT SELECTION: 
Patients reporting with symptoms of kudiveri Noi will be subjected to 
screening using screening Proforma. Then they will be allowed for the study fulfilling 
the following criteria 
 
INCLUSION CRITERIA:  
➢ Age: 18 -60.  
➢ Sex: Both Male and Female 
➢ Patients having history of alcohol and following symptoms 
❖ Physical symptoms like loss of appetite, nausea, vomiting, 
tremor. 
❖ Psychological symptoms like intoxication, craving/urge of 
alcohol, negligence of activity. 
➢ Patients who are willing to undergo hematological investigation 
&investigation & another lab investigation, 
➢ Patient willing to sign the informed consent stating that he/she will 
consciously stick to the treatment during 45days.  
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EXCLUSION CRITERIA:  
➢ Systemic diseases 
➢ Other psychiatric illness 
➢ Pregnancy and lactation 
➢ Withdrawal symptoms like seizure, delirium. 
➢ Any other serious illness 
 
WITHDRAWAL CRITERIA 
➢ Intolerance to the drug and development of adverse reactions during drug 
trial. 
➢ Poor patient compliance & defaulters. 
➢ Patient turned unwilling to continue in the course of clinical trial. 
➢ Any drastic changes occurring in haematological finding during treatment 
period. 
➢ Increase in severity of symptoms 
 
TESTS AND ASSESMENTS 
A. Clinical assessment  
B. Siddha assessment  
C. Laboratory investigations 
 
A. CLINICAL ASSESSMENT: 
❖ Acute intoxication, 
❖ Harmful use 
❖ Craving for alcohol 
❖ Tolerance level 
❖ Withdrawal symptoms 
❖ Neglect of Activities 
❖ Time spent in Alcohol-Related Activity 
❖ Inability to Fulfill Roles 
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B. SIDDHA SYSTEM OF EXAMINATION AND PHYSICAL SYMPTOMS: 
 
EN VAGAI THERVUGAL: 
1. Naadi 
                        2. Sparisam 
                        3. Naa 
                        4. Niram 
                        5. Mozhi 
                        6.Vizhi 
                        7. Malam 
                        8. Moothiram    
⚫ Neikuri                          
⚫ Neerkuri 
 
LABAROTARY INVESTIGATIONS: 
BLOOD 
Hb 
Total WBC Count 
DC - Polymorphs, Lymphocytes, Eosinophil, Monocytes, 
Basophils  
Total RBC count  
ESR 
 ½ hr 
 1 hr 
Blood sugar: 
Fasting 
Post prandial 
   Serum cholesterol 
 
LIVER FUNCTION TESTS 
       Serum total bilirubin 
                                    Direct bilirubin 
                                    Indirect bilirubin  
                  Serum Alkaline phosphatases 
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                                    SGOT 
                                    SGPT 
LIPID PROFILE: 
                        HDL:  
                        LDL:               
           VLDL:  
     Total Cholesterol  
                       TGL   
 
RENAL FUNCTION TESTS: 
   Urea 
Creatinine 
   Uric acid 
URINE: 
             Urine sugar 
             Albumin 
                                   Deposits 
OTHERS: 
VDRL. 
 HbsAg. 
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DATA COLLECTION FORMS: 
 
 Required information will be collected from each patient by using the 
following forms 
 
FORM I Screening and selection Proforma. 
FORM II Clinical assessment Proforma. 
FORM III        Laboratory investigation Proforma. 
FORM IV     Drug compliance form. 
FORM V       Patient information sheet. 
FORM VI      Consent form. 
FORM VII    Withdrawal form/Pharmacovigilance. 
FORM VIII    Dietary Advice form. 
FORM IX     Adverse reaction form 
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PATIENT SCREENING Inclusion/Exclusion 
 
INCLUSION CRITERIA EXCLUSION CRITERIA 
EXCLUDED FROM TRIAL 
METHODOLOGY 
STUDY NUMBER 
     HISTORY TAKING 
LAB INVESTIGATION 
 TRIAL DRUG  
CLINICAL ASSESSMENT 
OUTCOME 
INFORM ABOUT STUDY 
AND TRIAL DRUG 
 
INFORMED CONSENT 
FORM 
 
ADVERSE REACTION 
ADVICED TO TAKE 
TREATMENT IN OPD 
ABNORMAL VALUES 
VALUES 
PHARMACO 
VIGILANCE 
DEPARTMENT 
FURTHER 
MANAGEMENT 
OF ADVERSE 
DRUG REACTION 
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STUDY ENROLLMENT 
Patients reporting at the OPD with the clinical symptoms impaired control 
over drinking, pre-occupation with the drug alcohol, use of alcohol despite adverse 
consequences, and distortions in thinking etc. were examined clinically for enrolling 
in the study based on the inclusion and exclusion criteria.  
The patients who were enrolled would be informed (Form V) about the study, 
trial drug, possible outcomes and the objectives of the study in the language and terms 
understandable to them, and informed consent would be obtained in writing from 
them in the consent form (Form VI).  
Complete clinical history, complaints and duration, examination findings and 
laboratory investigations -- would be recorded in the prescribed Proforma. 
  Screening Form- I will be filled up, Form –II and Form –III will be used for 
recording the patients, history, clinical examination of symptoms and signs and 
laboratory investigations respectively. If there are any abnormal laboratory reports 
obtained then excluded from this study. Patients would be advised to take the trial 
drug and appropriate dietary advice (Form VIII)   would be given according to the 
patients, perfect understanding. 
CONDUCT OF THE STUDY: 
The trial drug Inji Choornam (Internal Medicine) being given for 45 days. 
Adviced the patient to oil bath with Arakku thylamand purgation with Meganaatha 
kulikai with ginger juice at early morning on next day before intake of trial drug. The 
OPD patients should visit the hospital once in 7 days (Form IV). At each clinical visit 
clinical assessment was done and prognosis was noted. If there was a need of IPD the 
patient will be admitted in ward for clinical assessment. For inpatients the trial drug is 
given for 45 days and the clinical assessment was done daily. The patients were 
advised to follow the specific dietary regimen during their treatment period. The 
results were compared at the end of the study. Laboratory investigations are done on 0 
day & 49th day of the trial. For In patients, who are not in a situation to stay in the 
hospital for a long time, are advised to attend the OPD for further follow-up. Siddha 
investigations like Neerkuri and Neikuri were carried over. After the end of the 
treatment, the patient is advised to visit the OPD for another 3 months for follow-up. 
If any trial patient who fails to collect the trial drug on the prescribed day but wants to 
75 
 
continue in the trial from the next day or two, he/ she was allowed, but defaulters of 
one week and more were not allowed to continue and be withdrawn from the study 
with a fresh case being included.  
DATA ANALYSIS: 
After enrolling the patient in the study, a separate file would be maintained for 
each and every patient and all forms and other information was kept in the file. The 
screening forms were filed separately. All collected data will be statistically analyzed 
by Sr. Research Officer (Statistics) for logical errors and incompleteness of data to 
avoid any bias. No modification in the results is permitted for unbiased reports. Then 
final report will be generated. 
ADVERSE EFFECT/SERIOUS EFFECT MANAGEMENT:  
                   If the trial patient develops any adverse reactions (Form IX), he/she 
would be immediately withdrawn from the trial and proper management will be given 
in OPD of National Institute of Siddha and the same will be informed to the 
Pharmaco-vigilance committee (Form VII) of NIS. 
 
OUTCOME: 
 
PRIMARY OUTCOME: 
I. Alcohol use disorders identification test(AUDIT). 
B. Alcohol use disorder identification test(AUDIT) 
The Alcohol Use Disorders Identification Test (AUDIT), developed in 1982 by the 
World 
Health Organization, is a simple way to screen and identify people at risk of alcohol 
Problems. 
BEFORE       AFTER 
TRIAL  TRIAL 
1. How often do you have a drink containing alcohol?    
(0) Never (Skip to Questions 9-10) 
(1) Monthly or less 
(2) 2 to 4 times a month 
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(3) 2 to 3 times a week 
(4) 4 or more times a week 
 
2. How many drinks containing alcohol do you have on a typical 
 day when you are drinking?        
(0) 1 or 2 
(1) 3 or 4 
(2) 5 or 6 
(3) 7, 8, or 9 
(4) 10 or more 
 
3. How often do you have six or more drinks on one occasion? 
(0) Never 
(1) Less than monthly 
(2) Monthly 
(3) Weekly 
(4) Daily or almost daily 
 
4. How often during the last year/Treatment period have you found that you 
were not able to stop drinking once you had started? 
(0) Never 
(1) Less than monthly 
(2) Monthly 
(3) Weekly 
(4) Daily or almost daily 
 
5. How often during the last year/Treatment period have you failed to do what 
was normally 
expected from you because of drinking? 
(0) Never 
(1) Less than monthly 
(2) Monthly 
(3) Weekly 
(4) Daily or almost daily 
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6. How often during the last year/Treatment period have you been unable to 
remember what happened the night before because you had been drinking? 
(0) Never 
(1) Less than monthly 
(2) Monthly 
(3) Weekly 
(4) Daily or almost daily 
 
7. How often during the last year/Treatment period have you needed an alcoholic 
drink first thing in the morning to get yourself going after a night of heavy 
drinking? 
(0) Never 
(1) Less than monthly 
(2) Monthly 
(3) Weekly 
(4) Daily or almost daily 
 
8. How often during the last year have you had a feeling of guilt or remorse 
after drinking? 
(0) Never 
(1) Less than monthly 
(2) Monthly 
(3) Weekly 
(4) Daily or almost daily 
 
9. Have you or someone else been injured as a result of your drinking? 
(0) No 
(2) Yes, but not in the last year 
(4) Yes, during the last year 
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10. Has a relative, friend, doctor, or another health professional expressed 
concern about your drinking or suggested you cut down? 
(0) No 
(2) Yes, but not in the last year 
(4) Yes, during the last year 
 
Add up the points associated with answers. A total score of 8 or more indicates 
harmful 
drinking behavior. 
 
Total  no of scoring-  
 
Score  0-7 :  No risk 
  
 Score  8-15 :   Mild risk 
  
Score 16-19 :   Moderate risk 
 
Score 20-40 :   Severe risk  
 
SECONDARY OUTCOME: 
 
1) To improve the other clinical symptoms. 
 a) Physical 
 b) Mental 
 c) Behavior 
 
2) Changes in blood SGOT, SGPT, MCV Levels. 
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OBSERVATION AND RESULTS 
 
The observation and results were studied and tabulated under the following heading.  
 
1. Age distribution  
2. Sex distribution  
3. Occupational status  
4. Family History  
5. Diet habits  
6. Thinai reference  
7. Paruvakaalam distribution (seasonal variation)  
8. Kaalam Distribution (According to Age) 
9. Yakkai Ilakkanam (Physical Constitution)  
10. Gunam reference (Character variation)  
11. Duration of illness  
12. Clinical features  
13. Distributions of Mukkutram 
14. UdarKattukkal reference (Body constituents)  
15. En Vagaithervugal(Eight type of examination)  
16. Neerkkuri, Neikkuri reference  
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1) Age Distribution  
 
 
 
S. No. Age No of Cases Percentage 
1. 20-30 04 13.3% 
2. 31-40 11 36.6% 
3. 41-50 08 26.6% 
4. 51-60 07 23.3% 
 
 
 
 
 
 
 
 
 
Observation:  
 
The patients were selected from all age groups as given above and the 
maximum numbers of patients (11) were in the age between 31 and 40. 
 
 
 
13.30%
36.60%
27.00%
23.00%
Age Distribution
20-30
31-40
41-50
51-60
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2) Sex Distribution: 
 
 
S. No. Sex No of Cases Percentage 
1. Male 30 100% 
2. Female 0 0% 
 
 
 
 
 
 
 
 
Observation:  
Among the 30 patients selected for this study, 100% were males and 
no females. 
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3) Occupational Status 
 
 
S. No. Nature of Work No. of Cases Percentage 
1. Driver 2 6% 
2. Shop Keeper 06 20% 
3. Tailor 2 6% 
4. Ryot 10 33.3% 
5. Private Office worker 7 23.3% 
6. Business man 03 10% 
 
 
 
 
 
 
 
Observation:  
The majority of patients in this study were Ryot 
 
6.00%
20.00%
6.00%
33.30%
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4) Family History 
 
 
S. No. Criteria No of Cases Percentage 
1. Family History - Present 19 63.3% 
2. Family History - Absent 11 36.6% 
 
 
 
 
 
 
 
 
Observation:  
63.30% of patients were positive family history 
 
 
 
63.30%
36.60%
Family History
Family History - Yes
Family History - No
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5) Dietary Habits 
 
 
Sl. No Dietary Habits No of Cases Percentage 
1. Vegetarian 2 6.6% 
2. Non -Vegetarian 28 93.3% 
 
 
 
 
 
 
 
 
 
 
Observation: 
  
93.30% of the patients were non-vegetarians. 
 
 
 
6.60%
93.30%
Dietary Habits
Vegetarian
Non Vegetarian
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6) Thinai Reference 
 
 
Sl.No Thinai No of Cases Percentage 
1. Kurinji (Hill Area) 0 0% 
2. Mullai (Forest Area) 0 0% 
3. Marutham (Fertile Land) 7 23.3% 
4. Neithal (Costal Area) 23 76.6% 
5. Paalai (Desert Land) 0 0% 
 
 
 
 
 
Observation: 
  
76% of the patients were from Neithal (Coastal Area) and the remaining 
(23.30%) from Marutham (Fertile Land). 
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0.00%
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7) Paruvakaalam distribution (seasonal variation): 
 
 
Sl. No. Kaalam 
Distribution 
No of Cases Percentage 
1. Kaar Kaalam 3 10% 
2. Koothir Kaalam 4 13.3% 
3. Munpani Kaalam 7 23.3% 
4. Pinpani Kaalam 5 16.6% 
5. Ilavenil Kaalam 11 36.6% 
6. Muthuvenil 0 0% 
 
 
 
 
 
 
Observation: 
 
Highest number of patients 11(36.6%) were treated during Ilavenil kalam. And 
7(23.30) cases who were treated in Munpani kalam. 
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8) Kaalam Distribution (According to Age): 
In Siddha literature human life has been divided into three periods as follows  
1) Vaatham  
2) Pitham  
3) Kabam  
 
The duration of each period is said to be 33 years 
 
Sl. No. Kaalam No of Cases Percentage 
1. Vaatha Kaalm (1-33) 7 23.3% 
2. Pitha Kaalam (34-66) 23 76.6% 
3. Kaba Kaalam (67-100) 0 0% 
 
 
 
 
 
 
Observation:  
 
Out of 30 patients, 23 (76.60) in Pitha kaalam and the remaining  
7 (23.30%) patients reported in Vaatha kaalam. 
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9) Yaakai Ilakkanam (Physical Constitution): 
 
 
Sl.No Yaakai Ilakkanam No. of Cases Percentage 
1. Vaatha Udal 0 0% 
2 Pittha Udal 0 0% 
3. Kaba Udal 0 0% 
4. Thontha Udal 30 100% 
 
 
 
 
 
 
 
 
Observation:  
 
All the patients (100%) had Thontha Udal 
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10) Gunam (Quality and Characters): 
 
 
Sl.No Gunam No. of Cases Percentage 
1. Sathuva Gunam 0 0% 
2. Rajo Gunam 0 0% 
3. Thamo Gunam 30 100% 
  
 
 
 
 
 
 
 
 
 
Observation:  
 
All the patients (100%) had “Thamo Gunam”. 
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11) Duration of Illness: 
 
 
Sl. No Duration of Illness No of Cases Percentage 
1. <1 Year 0 0% 
2. 1-10 Years 9 30% 
3. 11-20 Years 17 56.6% 
4. 21-30 Years 4 13.3% 
5. >30 Year 0 0% 
 
 
 
 
 
 
 
Observation:  
 
56.6% of the patients were suffering with the illness between 11-20year. 
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DURATION OF ILLNESS
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12) Clinical Features: 
 
Sl. No Clinical Features No of Cases Percentage 
1. Intoxication 20 67% 
2. Harmful use 25 83% 
3. Craving of alcohol 30 100% 
4. Withdrawal symptom 30 100% 
5. Negligence of activity 24 80% 
6. Time spent in alcohol related 
activity 
30 100% 
7. Family and social avoidance 10 33% 
8. Loss of appetite 30 100% 
 
 
 
 
Observation:  
All the patients had clinical feature of craving of alcohol, withdrawal 
symptom, loss appetite 
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13) Distribution of Mukkutram: 
 
Sl. No. Classification of 
Vaatham 
No of Cases Percentage 
1. Praanan 20 66.6% 
2. Abaanan 30 100% 
3. Udhaanan 30 100% 
4. Viyanan 30 100% 
5. Samaanan 30 100% 
6. Naagan 0 0% 
7. Koorman 0 0% 
8. Kirukaran 0 0% 
9. Devathatthan 28 93.3% 
10. Dananjayan 0 0% 
 
 
 
 
 
Observation: 
Praanan, Abaanan, Udaanan, Samaanan and Viyaanan were affected in 
all the 30 patients. Devathaththan were affected in 28 patients. 
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Piththam: 
 
 
Sl. No Classification of 
Pitham 
No of Cases Percentage 
1. Anar pitham 30 100% 
2. Ranjaga pitham 09 30% 
3. Saathaga pitham 30 100% 
4. Pirasaga pitham 0 0% 
5. Aalosaga pitham 0 0% 
 
 
 
 
 
 
 
Observation:  
Anarpiththamand, Ranjagapiththam thee was affected in all the cases. 
Saathagapitham was affected in 30% of the patients. 
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Kabam: 
 
 
Sl. No Classification of 
Kabam 
No of Cases Percentage 
1. Avalambagam 30 100% 
2. Kilethagam 30 100% 
3. Pothagam 18 60% 
4. Tharpagam 26 87% 
5. Santhigam 04 13% 
 
 
 
 
 
 
Observation: 
  
Avalambagam, kiletham were affected in all cases 
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14) Udal Kattukkal: 
 
Sl. No Udal Kattukkal No of Cases Percentage 
1. Saaram 30 100% 
2. Senneer 30 100% 
3. Oon 30 100% 
4. Kozhuppu 30 100% 
5. Enbu 20 67% 
6. Moolai 0 0% 
7. Sukkilam/Suronitham 0 0% 
 
 
 
 
Observation:  
 
Among 30 patients, Saaram and Seneer,Oon,Kozhupu were affected in all 
the cases. 
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15) Envagai Thervugal 
 
 
Sl. No Envagai Thervugal No of Cases Percentage 
1. Naadi 
a. Vatha pitham 8 26% 
b. Pitha vatham 16 53.3% 
c. Vadha kabam 2 6.6% 
d. Kabavatham 2 6.6% 
2. Sparisam 0 0% 
3. Naa 0 0% 
4. Niram 0 0% 
5. Mozhi 0 0% 
6. Vizhi 0 0% 
7. Malam 21 70% 
8 Moothiram 0 0% 
 
 
 
Observation: 
In Envagai thervugal, malam were found affected in the 21 (70%) cases. 
The Naadinadai seen in Kudiveri noi patients were Vaathapitham 8 (67.5%), 
Pithavaatham 16 (53.3 %), Vathakabam 2 (6.6%), Kabapitham 2 (6.6%). 
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15) a. Neerkuri and Neikkuri 
 
Sl. No Type of Test No of Cases Percentage 
1. Neerkkuri 
“Niram”-Pale yellow 
-Dark yellow 
17 
 
13 
56.6% 
 
43.3% 
2. Neikkuri 
(Vaadham) “Aravna 
Neendal” 
11 37% 
(Pitham) “Azhipol 
Paraviyathu 
6 20% 
(Kabam) “Muththothu 
ninrathu” 
13 43% 
Others 0 0% 
 
 
 
 
 
Observation: 
  
Among 30 patients 17 cases were Ila manjal(Pale yellow) and 13 were 
Manjal(Dark yellow). Neikurishows Vatha, Pitha, kapha neer observed 11 
cases (36.6%),6 cases (20%),13 cases (43%). 
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17(A). Results OP CASES CLINICAL IMPROVEMENT (AUDIT SCORE) 
 
 
Sl. No OP No. AGE/SEX BT AT RESULT 
1. J 19962 36/M  29   7 Good 
2. J 06767 28/M  28 10 Moderate 
3. J 63348 37/M  22  7 Good 
4.  J 57783 50/M  26  5 Good 
5. J 65563 43/M  28  9 Moderate 
6. J 28820 31/M  30  8 Moderate 
7. J 66459 24/M  25  10 Moderate 
8. J 99119 52/M  30 15 Moderate 
9. J 62510 41/M  23 19 Mild 
10. J 31942 48/M  28 5 Good 
11. J 69094 56/M  24 6 Good 
12. J 53489 35/M  22 7 Good 
13. J 92493 36/M  27 19 Mild 
14. J 94819 24/M  29 6 Good 
15. J 10134 40/M  28 5 Good 
16. K 00521 57/M  23 7 Good 
17. J 99542 46/M  23 8 Moderate 
18. K 03222 45/M  27 9 Moderate 
19. J 94960 40/M  26 16 Mild 
20. K 11710 57/M  30 5 Good 
21. K 13119 58/M  26 7 Good 
22. J 99595 37/M  25 9 Moderate 
23. J 86642 37/M  28 14 Moderate 
24. K 07426 38/M  28 7 Good 
25. K 16005 45/M  26 21 Poor 
26. K 20571 31/M  25 16 Mild 
27. K 11318 28/M  29 14 Moderate 
28. K 19169 31/M  30 7 Good 
29. K 0421 45/M  25 8 Moderate 
30. K 27863 48/M  30 22 Poor 
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Sl.No Result No of cases Percentage 
1 Good 13 43% 
2 Moderate 11 37% 
3 Mild 4 13% 
4 Poor 2 7% 
 
 
 
 
 
 
 
 
 
 
 
 
Observation:  
Among 30 cases 13 cases were good improvement, 11 cases were 
moderate improvement, cases 
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INVESTIGATIONS BEFORE AND AFTER TREATMENT- THE OPD PATIENTS 
 
S. 
NO. 
 
 
IP / OP NO. 
 
AGE / 
SEX 
 
Hb (gm/ dl) 
TOTAL  
RBC COUNT 
(million/ 
cu.mm) 
ESR (mm/ hour) TOTAL WBC 
(cells/ cu.mm) 
BT AT BT AT BT AT BT AT 
1. J 19962 36/M 16.2 15 4.5 4.5 16/50 8/16 4600 7300 
2. J 06767 28/M 14.4 13.6 5.0 4.5 5/10 2/4 9400 9200 
3. J 63348 37/M 13.9 13.9 4.5 4.0 10/20 5/10 8300 7500 
4. J 57783 50/M 15.5 14.0 4.0 5.2 12/20 2/4 5500 4900 
5. J 65563 43/M 11.0 13.0 5.5 5.5 5/15 3/10 8900 8500 
6. J 28820 31/M 17 16 4.1 4.7 2/4 2/4 9500 7200 
7. J 66459 24/M 15 13 5.6 5.1 6/12 6/10 7500 9400 
8. J 99119 52/M 16 15.2 4.3 4.1 8/20 6/14 4800 7000 
9. J 62510 41/M 12 14 4.7 5.0 4/10 2/4 6200 4500 
10. J 31942 48/M 15 16.2 4.0 4.6 6/12 4/8 3500 6500 
11. J 69094 56/M 11 14 5.6 4.8 2/4 3/9 5500 7000 
12. J 53489 35/M 13 12.5 5.1 5.4 8/16 4/10 6400 6700 
13. J 92493 36/M 11.5 15.1 4.1 4.1 5/18 6/16 7200 7600 
14. J 94819 24/M 12.9 13 4.3 4.0 2/4 2/4 3900 4400 
15. J 10134 40/M 17 13.2 5.4 4.4 4/10 3/9 4800 5600 
16. K 00521 57/M 18 11.5 5.3 5.3 7/20 6/16 5500 9400 
17. J 99542 46/M 15.5 13 5.1 5.0 20/40 10/20 6100 5500 
18. K 03222 45/M 16.4 14.4 4.1 4.6 12/30 6/10 9800 7500 
19. J 94960 40/M 12 15.5 5.2 5.1 2/8 2/4 4800 5500 
20. K 11710 57/M 18 12.6 4.8 4.8 4/16 3/12 5900 6000 
21. K 13119 58/M 14.2 12 5.3 4.3 5/10 4/8 7700 8000 
22. J 99595 37/M 13.1 15 6.6 6.0 8/25 4/20 9000 5400 
23. J 86642 37/M 11 13 4.6 5.0 3/9 3/6 7000 3600 
24. K 07426 38/M 17 13 4.9 4.6 8/10 8/10 9100 8100 
25. K 16005 45/M 15 16 6.1 5.8 3/6 2/4 6300 4500 
26. K 20571 31/M 16 14 5.7 4.1 5/15 2/4 5400 5700 
27. K 11318 28/M 13.5 12.3 5.0 5.0 4/10 1/6l 4100 5500 
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INVESTIGATIONS BEFORE AND AFTER TREATMENT - THE OPD PATIENTS 
S. 
No. 
OP/IP No. AGE/S
EX 
BLOOD (mg/dl) UREA CREATININ
E (mg/dl) 
FASTING 
(mg/dl) 
POST 
PRANDIAL 
(mg/dl) 
BT AT BT AT BT AT BT AT 
1. J 19962 36/M 111 100 198 169 16 17 1.8 1.1 
2. J 06767 28/M 81 90 120 119 22 30 0.8 1.0 
3. J 63348 37/M 90 95 114 100 28 30 0.9 0.9 
4. J 57783 50/M 110 109 160 140 19 20 1.4 0.9 
5. J 65563 43/M 127 120 141 150 19 13 1.0 1.2 
6. J 28820 31/M 100 110 140 130 26 19 0.9 0.8 
7. J 66459 24/M 89 99 121 130 12 12 1.3 1.0 
8. J 99119 52/M 105 120 126 140 39 20 1.3 1.8 
9. J 62510 41/M 109 108 150 160 28 25 1.0 1.0 
10. J 31942 48/M 204 220 150 175 29 27 0.8 0.6 
11. J 69094 56/M 111 120 147 140 36 30 0.5 0.9 
12. J 53489 35/M 87 100 153 160 15 17 1.5 1.1 
13. J 92493 36/M 90 120 138 140 11 17 2.0 1.0 
14. J 94819 24/M 101 99 126 130 21 23 1.7 0.6 
15. J 10134 40/M 121 100 135 140 24 24 1.4 0.9 
16. K 00521 57/M 100 109 140 156 21 21 1.9 1.2 
17. J 99542 46/M 94 100 130 130 24 26 0.5 1.2 
18. K 03222 45/M 89 101 125 135 21 21 0.8 1.0 
19. J 94960 40/M 90 87 140 145 27 30 1.4 0.8 
28. K 19169 31/M 14.6 16 4.6 5.3 10/30 3/6 5800 4200 
29. K 0421 45/M 14.4 14 5.8 5.4 4/10 6/8 7300 6400 
30. K 27863 48/M 12 15 4.9 4.1 2/6 2/4 8008 5800 
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20. K 11710 57/M 98 90 122 135 25 21 0.9 0.4 
21. K 13119 58/M 100 106 145 150 14 18 1.0 1.1 
22. J 99595 37/M 120 117 150 145 14 16 0.9 0.9 
23. J 86642 37/M 127 130 135 140 13 14 1.3 1.2 
24. K 07426 38/M 98 110 115 145 15 20 1.5 1.0 
25. K 16005 45/M 101 100 128 135 19 21 1.3 1.5 
26. K 20571 31/M 108 110 130 140 27 25 0.7 1.1 
27. K 11318 28/M 110 89 130 125 15 20 1.0 0.9 
28. K 19169 31/M 116 90 130 129 19 19 1.7 0.7 
29. K 0421 45/M 99 98 135 135 20 20 1.2 1.2 
30. K 27863 48/M 100 106 135 125 17 18 0.9 1.1 
 
 
 
INVESTIGATIONS BEFORE AND AFTER TREATMENT - THE OPD PATIENTS 
S. 
No. 
OP/IP NO. AGE/
SEX 
URINE 
SUGAR (F) 
URINE 
SUGAR 
(PP) 
ALBUMIN DEPOSITS 
Epithelial 
cells 
Pus cells 
BT AT BT AT BT AT BT AT BT AT 
1. J 19962 36/M Nil Nil Nil Nil Nil Nil 2-3 1-2 2-4 1-2 
2. J 06767 28/M Nil Nil Nil Nil Nil Nil 2-3 1-3 2-3 1-3 
3. J 63348 37/M Nil Nil Nil Nil Nil Nil 4-6 2-4 3-4 4-6 
4. J 57783 50/M Nil Nil Nil Nil Nil Nil 2-3 1-2 1-2 3-4 
5. J 65563 43/M Nil Nil Nil Nil Nil Nil 2-3 1-5 2-3 1-3 
6. J 28820 31/M Nil Nil Nil Nil Nil Nil 1-2 1-2 4-6 2-3 
7. J 66459 24/M Nil Nil Nil Nil Nil Nil 2-4 1-2 2-3 2-6 
8. J 99119 52/M Nil Nil Nil Nil Nil Nil 4-6 2-3 1-2 1-2 
9. J 62510 41/M Nil Nil Nil Nil Nil Nil 2-4 2-3 2-3 2-3 
10. J 31942 48/M Nil Nil Nil Nil Nil Nil 2-4 1-3 2-4 1-2 
11. J 69094 56/M Nil Nil Nil Nil Nil Nil 2-4 1-3 2-4 2-6 
12. J 53489 35/M Nil Nil Nil Nil Nil Nil 2-4 1-2 3-5 1-5 
13. J 92493 36/M Nil Nil Nil Nil Nil Nil 6-8 4-5 1-2 1-3 
14. J 94819 24/M Nil Nil Nil Nil Nil Nil 3-5 1-2 3-5 2-3 
15. J 10134 40/M Nil Nil Nil Nil Nil Nil 1-2 1-2 1-3 1-3 
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16. K 00521 57/M Nil Nil Nil Nil Nil Nil 1-2 4-5 2-4 1-2 
17. J 99542 46/M Nil Nil Nil Nil Nil Nil 6-8 6-7 1-5 1-3 
18. K 03222 45/M Nil Nil Nil Nil Nil Nil 2-3 1-2 3-5 3-5 
19. J 94960 40/M Nil Nil Nil Nil Nil Nil 2-3 1-3 3-5 2-3 
20. K 11710 57/M Nil Nil Nil Nil Nil Nil 3-5 1-3 1-2 1-2 
21. K 13119 58/M Nil Nil Nil Nil Nil Nil 3-5 1-2 4-6 4-6 
22. J 99595 37/M Nil Nil Nil Nil Nil Nil 1-3 1-3 3-5 2-5 
23. J 86642 37/M Nil Nil Nil Nil Nil Nil 4-6 4-6 1-2 1-3 
24. K 07426 38/M Nil Nil Nil Nil Nil Nil 4-6 1-2 2-4 2-4 
25. K 16005 45/M Nil Nil Nil Nil Nil Nil 2-4 1-2 3-5 2-6 
26. K 20571 31/M Nil Nil Nil Nil Nil Nil 1-2 1-2 1-3 1-5 
27. K 11318 28/M Nil Nil Nil Nil Nil Nil 2-3 1-2 3-4 1-4 
28. K 19169 31/M Nil Nil Nil Nil Nil Nil 2-4 0-1 1-3 2-3 
29. K 0421 45/M Nil Nil Nil Nil Nil Nil 1-2 1-2 2-3 2-4 
30. K 27863 48/M Nil Nil Nil Nil Nil Nil 2-4 1-2 3-5 1-2 
 
 
 
 
LIVER FUNCTION TESTS BEFORE AND AFTER TREATMENT - THE OPD PATIENTS 
 
 
S. 
No 
 
OP/IP No 
 
AGE
/SEX 
 
SGOT 
(IU/L) 
 
SGPT 
(IU/L) 
 
AL. PHOS 
(U/dl) 
 
ALBUMI
N (g/dl) 
 
GLOBULIN 
(g/dl) 
T. 
PROTEIN 
(g/dl) 
   BT AT BT AT BT AT BT AT BT AT BT AT 
1. J 19962 36/M 30 35 34 39 111 96 3.2 3.1 3.1 2.6 6.2 6.0 
2. J 06767 28/M 46 45 20 23 72 88 4.2 4.5 3.3 2.1 7.5 8.4 
3. J 63348 37/M 17 20 15 18 190 200 4.4 4.0 2.3 3.1 6.7 8.2 
4. J 57783 50/M 18 40 14 30 66 93 4.3 3.9 2.6 3.1 6.9 7.9 
5. J 65563 43/M 18 23 03 34 98 56 4.7 4.6 3.0 2.3 7.5 6.7 
6. J 28820 31/M 20 20 23 20 61 62 4.5 4.5 3.7 3.4 8.4 6.5 
7. J 66459 24/M 24 17 11 16 111 121 7.4 7.8 3.1 3.3 7.4 7.1 
8. J 99119 52/M 51 21 33 10 75 64 5.4 4.8 2.6 3.7 8.4 7.4 
9. J 62510 41/M 23 26 30 22 81 75 4.8 4.7 3.1 3.1 6.4 7.1 
10. J 31942 48/M 20 19 14 16 112 79 4.0 4.5 3.2 3.2 6.1 6.0 
11. J 69094 56/M 35 22 48 32 48 27 7.0 7.0 3.9 3.9 8.6 8.4 
12. J 53489 35/M 45 19 31 16 46 38 4.6 4.8 2.6 2.9 7.0 7.4 
13. J 92493 36/M 38 27 17 29 43 70 4.9 4.4 2.9 2.6 8.2 6.4 
14. J 94819 24/M 28 30 26 28 94 100 4.3 4.6 3.0 3.0 8.5 2.9 
15. J 10134 40/M 85 79 72 68 67 79 4.5 4.2 2.0 2.0 7.8 7.2 
16. K00521 57/M 22 21 15 19 64 53 4.2 5.0 2.8 2.8 6.3 7.3 
17. J 99542 46/M 27 20 52 46 71 86 3.5 4.8 3.2 2.2 6.7 8.1 
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18. K 03222 45/M 61 63 46 41 190 185 3.9 4.5 2.6 3.2 7.1 7.9 
19. J 94960 40/M 22 25 19 32 57 60 4.1 4.7 2.6 2.6 8.5 7.2 
20. K 11710 57/M 109 100 64 69 111 149 4.7 5.1 3.5 3.8 7.9 8.0 
21. K 13119 58/M 26 30 13 19 51 70 4.7 5.0 5.3 2.9 6.1 7.1 
22. J 99595 37/M 30 39 11 20 50 93 4.9 4.9 2.7 3.6 6.4 6.9 
23. J 86642 37/M 40 45 34 34 96 80 3.1 4.1 3.5 3.0 7.3 7.1 
24. K 07426 38/M 57 64 60 54 140 130 3.7 4.0 2.9 2.8 6.9 8.3 
25. K 16005 45/M 19 20 46 46 90 103 3.6 3.9 3.0 2.4 8.2 6.9 
26. K 20571 31/M 43 62 20 19 50 40 4.7 3.4 3.4 3.0 7.2 6.1 
27. K 11318 28/M 16 41 65 69 100 90 3.9 3.1 2.5 2.9 6.1 5.8 
28. K 19169 31/M 24 20 80 10 44 36 4.9 4.1 3.0 3.0 7.6 6.6 
29. K 0421 45/M 30 31 31 29 60 59 4.4 3.9 2.2 2.9 7.3 7.9 
30. K 27863 48/M 21 25 14 20 66 70 4.3 3.2 2.8 2.2 7.5 7.6 
 
 
 
LIVER FUNCTION TESTS BEFORE AND AFTER TREATMENT 
 - THE OPD PATIENTS 
S.NO. IP/OP NO AGE / 
SEX 
TOTAL 
BILIRUBIN 
DIRECT 
BILIRUBIN 
INDIRECT 
BILIRUBIN 
BT AT BT AT BT AT 
1. J 19962 36/M 2.0 1.2 0.3 0.3 0.2 0.2 
2. J 06767 28/M 1.1 0.9 0.8 0.2 0.9 0.3 
3. J 63348 37/M 0.9 1.0 0.8 0.4 0.8 0.4 
4. J 57783 50/M 1.8 0.7 1.2 0.2 1.4 0.2 
5. J 65563 43/M 1.4 0.4 0.5 0.5 0.8 0.3 
6. J 28820 31/M 0.7 0.3 0.4 0.3 0.5 0.3 
7. J 66459 24/M 1.4 1.1 0.2 0.2 1.2 0.4 
8. J 99119 52/M 2.2 1.3 0.8 0.7 0.9 0.3 
9. J 62510 41/M 0.6 0.3 0.7 0.7 0.5 0.9 
10. J 31942 48/M 1.8 1.7 0.7 0.2 0.9 1.1 
11. J 69094 56/M 2.0 0.9 0.7 0.3 0.7 0.7 
12. J 53489 35/M 1.7 1.1 3.0 2.0 1.9 1.1 
13. J 92493 36/M 1.1 0.8 2.8 1.0 0.9 0.8 
14. J 94819 24/M 0.9 0.4 1.9 0.9 1.0 1.0 
15. J 10134 40/M 0.2 0.2 0.6 0.3 0.2 0.2 
16. K 00521 57/M 0.9 0.9 2.1 1.6 1.9 0.9 
17. J 99542 46/M 1.1 0.3 0.3 0.2 0.4 1.1 
18. K 03222 45/M 1.9 0.3 0.2 0-2 0.8 1.0 
19. J 94960 40/M 2.0 1.1 1.2 1.0 1.8 1.1 
20. K 11710 57/M 1.1 1.4 0.4 0.4 0.5 0.3 
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21. K 13119 58/M 0.4 0.2 0.2 0.2 0.3 0.5 
22. J 99595 37/M 0.9 0.2 0.5 0.6 0.4 0.3 
23. J 86642 37/M 2.0 0.5 0.4 0.2 0.4 0.2 
24. K 07426 38/M 2.8 2.0 2.0 1.9 2.1 0.4 
25. K 16005 45/M 3.0 2.0 2.8 1.9 2.5 0.9 
26. K 20571 31/M 1.1 1.0 1.7 1.1 0.9 0.8 
27. K 11318 28/M 2.3 1.3 1.8 1.2 1.0 1.0 
28. K 19169 31/M 0.9 0.9 0.8 0.7 0.8 0.4 
29. K 0421 45/M 2.8 1.9 2.0 1.5 2.6 0.8 
30. K 27863 48/M 1.9 1.1 1.7 1.2 1.5 0.9 
 
 
CHOLESTEROL PROFILE OF THE OPD PATIENTS (BEFORE AND AFTER TREATMENT) 
 
S. 
No. 
IP/OP 
No 
AGE/
SEX 
T. 
CHOLESTE
ROL (mg/dl) 
HDL 
(mg/dl) 
LDL 
(mg/dl) 
VLDL 
(mg/dl) 
TGL 
(mg/dl) 
   BT AT BT AT BT AT BT AT BT AT 
1. J 19962 36/M 109 99 42 39 69 50 27 20 130 101 
2. J 06767 28/M 90 89 62 59 75 74 30 19 145 121 
3. J 63348 37/M 199 184 83 71 121 110 41 25 90 71 
4. J 57783 50/M 130 125 46 40 70 68 35 20 51 49 
5. J 65563 43/M 178 169 52 45 107 97 27 36 81 91 
6. J 28820 31/M 220 211 39 35 145 157 18 19 150 140 
7. J 66459 24/M 190 179 94 85 90 81 28 30 85 19 
8. J 99119 52/M 260 251 52 47 135 110 17 29 59 41 
9. J 62510 41/M 220 192 66 51 80 90 35 30 74 60 
10. J 31942 48/M 154 141 59 50 74 89 26 19 185 177 
11. J 69094 56/M 160 151 121 96 160 125 04 12 100 77 
12. J 53489 35/M 221 219 99 90 89 99 37 19 69 58 
13. J 92493 36/M 150 131 70 65 103 109 19 20 81 90 
14. J 94819 24/M 184 171 76 70 100 80 25 30 171 155 
15. J 10134 40/M 211 201 53 49 70 65 42 39 95 96 
16. K 00521 57/M 145 141 62 64 110 96 29 26 86 80 
17. J 99542 46/M 169 151 94 89 125 101 24 20 115 101 
18. K 03222 45/M 144 139 58 45 110 91 39 40 76 82 
19. J 94960 40/M 188 178 71 68 104 100 19 14 178 169 
20. K 11710 57/M 176 161 89 81 90 74 28 18 110 112 
21. K 13119 58/M 166 155 70 61 79 85 36 29 89 90 
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22. J 99595 37/M 182 170 44 41 124 109 19 11 67 70 
23. J 86642 37/M 169 164 40 39 135 118 25 17 174 147 
24. K 07426 38/M 145 138 71 67 104 110 06 12 48 80 
25. K 16005 45/M 171 169 51 69 96 90 28 15 75 59 
26. K 20571 31/M 181 174 86 80 84 75 09 15 82 75 
27. K 11318 28/M 218 180 67 70 120 90 15 30 100 89 
28. K 19169 31/M 169 150 79 80 124 110 24 20 154 138 
29. K 0421 45/M 189 154 70 65 73 89 35 26 121 100 
30. K 27863 48/M 156 151 81 79 110 80 18 15 94 60 
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STATISTIC ANALYSIS 
 
All collected data were entered into MS Excel software using different 
columns as variables and rows as patients. SPSS software was used to perform 
statistical analysis. Basic descriptive statistics include frequency distributions and 
cross-tabulations were performed. The quantity variables were expressed as Mean ± 
Standard Deviation and qualitative data as percentage. A probability value of <0.05 
was considered to indicate as statistical significance. Paired ‘t’ test was performed for 
determining the significance between before and after treatment. 
 
Paired Sample Statistics (AUDIT Score Before Treatment and After Treatment)  
 
 
Variable Obs Mean±SD t Value p Value 
Before 
treatment 
30 26.6 ± 2.5          15.7 <0.0001 
After treatment 30 10.3 ± 5.13 15.7 <0.0001 
 
 
The mean ± standard deviation of AUDIT score at before and after 
treatment were 26.6 ± 2.5 and 10.3 ± 5.13 respectively which is statistically 
significant (t=15.7. p <0.0001).  
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DISCUSSION  
 
 India’s reputation as a country with a culture of abstinence especially in 
matters regarding alcohol is underserved. In the recent years there has been rapid 
proliferation of city bars and nightclubs and people are fast shedding their inhibitions 
about alcohol as a lifestyle choice.  
While some states such as Nagaland, Gujarat, and Manipur have managed to 
ban the sale and consumption of alcohol, other states such as Tamil Nadu and 
Pondicherry continue to generate more revenue from the sale of alcohol.  
The Government of Tamil Nadu sells alcohol via Tamil Nadu State Marketing 
Corporation Limited (TASMAC), and licensed pubs.  Though the Tamil Nadu 
Prohibition Act, 1937 requires alcohol consumers to be at least 21 years, considerable 
drinkers are found to be below this age.  
For this dissertation study, 30 patients were selected and they were treated in 
the OPD, Department of Sirappu Maruthuvam in Ayothidoss Pandithar Hospital, 
National Institute of Siddha, Tambaram Sanatorium Chennai -600 047.  
This study has been carried out in a selected people who were attended for 
their treatment at this hospital not been in a general population.       
Even though the drug was mentioned in Siddha literature and practiced in 
traditional Siddha physicians in Tamilnadu, based on various criteria, the data were 
collected and tabulated. The criteria were family history, sex predominance, age 
distribution, occupation, dietary habit of patient and incidence of the disease with 
reference to thinai, seasonal variation, clinical manifestation and assessment of the 
improvement in the prognosis of disease with the trial drug.  
Among 30 cases all 30 (100%) were male and no female case reported. Most 
of the Indian based studies in related alcoholism, the female population was not 
included in their studies. According to the Tamil culture set-up, most of the females 
are reluctant to talk on such sensitive issues due to social stigma in their personnel 
lives. A study which was done in Faridabad showed the prevalence of alcohol use to 
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be 24.6% among men, while none of the women had used alcohol. In contrast, A 
cross sectional study were done in Villupuram district in Tamilnadu shows the female 
drinkers prevalence was reported in 1.3% (Ganesh Kumar. S et al) and at 
Andrapradesh, female drinker’s prevalence was high, the reason may be their cultural 
belief that toddy improves the fetal movements, facilitates easy expulsion of placenta 
on child birth (labour) and during pregnancy period the toddy acts as a diuretic which 
is prevent pre-eclampsia in pregnancy (Padmavathy et al).   
The study shows within 30 cases, 7 (23.3%) patients age was between 51- 60 
years, 11 (36.6%) patients were between 31 and 40 years. 
 Similarly, in the study carried out by Dhupdale et al, the prevalence of alcohol 
consumption showed a peak near age 40. They found that 58.3% individuals in age 
group between 45 – 54 years old.   
Fathima et al. carried out a study in rural Bangalore and found that prevalence 
of alcohol consumption was higher (43.1%) in the age group 41–60.   
This dissertation study may have correlated with other studies factors such as 
lower literacy level, family history of alcohol consumption, and cigarette smoking 
were found to be positively associated with alcohol consumption. This is also being 
compared with the dissertation study showing the 63.3% of people were positive 
family history. Similarly, Dhupdale et alreported that having an alcoholic father was a 
risk factor for being an alcohol consumer (above 55%). 
Meena et al. in their study conducted in Rohtak, found that 23.16% of alcohol 
users had an alcoholic father and 7.5% had alcoholic grandfather. 
In this present study, considerable number of patients were reported form 
Neithal and Marutham thinai.  
Highest number of patients 11(36.6%) were treated during Ilavenil kalam.and 
7 cases who were treated in Munpani kalam. The complete observation shows that 
most of the cases were affected in seven body constituents like saram, seneer, oon, 
kozhuppu, enbu, moolai, sukkilam or suronitham mentioned as per the Siddha texts. 
Craving of alcohol, withdrawal symptoms, loss of appetite was present in all 30 cases. 
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Harmful use was present in 25 cases. The other important features were Negligence of 
activity present in 24 cases and family and social avoidance were observed in 10 
cases. 
 
Treatment 
The following medicines were selected for this study to evaluate the efficacy 
as a trial drug.   
1st day Oil bath with Arakku thylam (early morning before sunrise) 
2nd day Purgation with Meganaatha kuligai (Early morning with ginger juice) 
3rd day Advised to take rest 
4th day Trail drug of Inji chooranam– 2gm two times a day with warm water. 
 
Before enrolling the cases, patient went under counselling to explain the 
complication of alcohol intake, like physical, mental, social and economic impact. 
Further it was provided awareness of alcoholism for all 30 patients. During the 
treatment period frequency of alcohol intake, family and social interaction were 
monitored by family attendees and also advice to follow the pathiyam (Dietary 
regimen). Withdrawal symptoms like sleep disturbance, tremor, alcoholic 
hallucination and palpitation were reduced within 3-5 days. None of patients reported 
in severe withdrawal symptoms like seizure and delirium.  In this study no, adverse 
events were observed during the course of the treatment. The outcome by AUDIT 
score, which has been validated and widely used in India. Which shows encouraging 
results of good improvement in 13patients (43%) moderate improvement in 11patients 
(37%), mild improvement in 4patients (13%) and poor improvement in 2 patients 
(7%) of cases. Nearly 5% of patient was drop-out from the study due to 
noncompliance consumption of medication. Good Improvement was observed in 
voluntary cases and person who were strong desired to stop alcohol intake. Patient 
didn’t show any symptoms like aversion therapy clinically, during the treatment 
period. Laboratory investigation was done for all the cases before and after treatment. 
There was no variation in renal profiles and other parameters. Abnormal values 
shown in Liver function test was noted in most of the patients and which considerably 
reduced in after treatment. Further patients were monitored after treatment by a period 
of 1 month.  
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SUMMARY  
 
The disease Kudiveri noi was taken for the clinical study with Inji chooranam 
as internal medicine. For the clinical study, 30 cases were selected based on the 
approved protocol. This study has been approved by IEC of NIS[Date of IEC 
Approval & its number: NIS/IEC/2016/11-10/14.10. 2016.The trial was registered in 
Clinical Trial Registry of india (CTRI/. All 30 cases were treated in OPD of 
Ayothidoss Pandithar Hospital of National Institute of Siddha, Chennai-47. The 
detailed study on Kudiveri noi with reference to its aetiology, pathogenesis, 
investigations, clinical features, diagnosis and treatment with trial drugs was done. 
The results were observed by AUDIT score. Among the 30 cases treated, of good 
improvement in 13patients (43%) moderate improvement in 11patients (37%), mild 
improvement in 4patients (13%) and poor improvement in 2 patients (7%) of cases.  
 
 
CONCLUSION  
 
The polyherbal formulation Inji chooranam exhibited no toxicity on short 
form administration. There was no adverse effect reported during the study period. 
The quantitative outcome of AUDIT score shows there is significant reduction 
between at the start and end of treatment i.e. the mean and standard deviation is from 
26.6 ± 2.5 and 10.3 ± 5.13.  The qualitative outcome shows encouraging results of 
good improvement in 13patients (43%) moderate improvement in 11patients (37%), 
mild improvement in 4 patients (13%) and poor improvement in 2 patients (7%). 
From the above results, the trail drugs “Inji chooranam” (Internal Medicine) is 
responded well for the treatment of Kudiveri noi. 
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FROM - I   SCRENING &SELECTION PROFOMA: 
 
NATIONAL INSTITUTE OF SIDDHA 
AYOTHIDOSS PANDITHAR HOSPITAL, CHENNAI – 600 047. 
 
POST-GRADUATE DEPARTMENT OF SIRAPPU MARUTHUVAM 
 
 
An open clinical trial to Evaluate the Therapeutic Efficacy of Siddha Herbal 
formulation Inji Chooranam for the treatment of  Kudiveri Noi (Chronic 
Alcoholism)” 
 
 
Principal Investigator: 
 
Reg. No: 
 
 
1. SERIAL NO :          
 
2. OP /IP NO: -------------                 
 
3. NAME: ……………………………………      
 
4. AGE/GENDER: ………….......   
 
5. OCCUPATION: ……………………       
 
6. INCOME:   ………………… 
 
INCLUSION CRITERIA 
 
⚫ Whether age is between 18-60                                  YES\ NO 
⚫ Sex                            M \ F 
⚫ Loss of appetite        YES\ NO  
⚫ Nausea,vomiting    YES\ NO                    
⚫ Tremor        YES\ NO       
⚫ Intoxication state           YES\NO  
⚫ Craving/urge of alcohol       YES\ NO 
⚫ Negligence of activity       YES\ NO 
⚫ willing to attend OPD or admission in IPD for the trial   YES\ NO 
⚫ Willingness for consent        YES\ NO 
⚫ Willing to give specimen of blood for the investigation     YES\ NO 
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EXCLUSION CRITERIA: 
 
⚫ Systemic diseases      YES\ NO 
⚫ Other psychiatric illness      YES\ NO 
⚫ Withdrawal symptoms like seizure, delirium   YES\ NO 
⚫ Pregnancy and lactation      YES\ NO 
⚫ Patient with any other serious systemic illness   YES\ NO 
 
 
 
ADMITTED TO TRAIL 
 
YES  NO  
If Yes, OPD  IPD  
  
 
Serial NO: 
 
 
 
Date:        
Station: 
 
 
Signature of the Investigator: 
 
 
 
Signature  of the Lecturer:      Signature of the HOD   
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NATIONAL INSTITUTE OF SIDDHA 
AYOTHIDOSS PANDITHAR HOSPITAL, CHENNAI – 600 047. 
 
POST-GRADUATE DEPARTMENT OF SIRAPPU MARUTHUVAM 
 
An open clinical trial to Evaluate the Therapeutic Efficacy of Siddha Herbal 
formulation Inji Chooranam for the treatment of  Kudiverinoi (Chronic Alcoholism) 
 
Principal Investigator:  
 
Reg. No:  
FORM II  
 
HISTORY TAKING PROFOMA 
 
 
STUDY NO: 
 
 
OP / IP NO: 
NAME: 
 
AGE / GENDER: 
ADDRESS: 
 
CONTACT NO: 
 RELIGION:  H / C / M / O. 
 
OCCUPATION: 
 
INCOME: 
DATE OF INTIAL ASSESSMENT: 
 
 
COMPLAINTS & DURATION:  
 
 
 
 
                                                                                                                                                                             
I.PERSONAL HISTORY: 
 
1)ALCOHOLIC HISTORY: 
 
1. Type of drink  : 
 
2. Frequency  : 
     Per day   - 
  Per week-  
 
3. Quantity / intake : 
 
 
 
 
 
 
4. CAGE - Questionnaire: 
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1.Have you ever felt you ought to cut down 
on your drinking? 
 
2.Have people annoyed you by criticizing 
your drinking? 
 
3.Have you ever felt guilty about your 
drinking? 
 
 
4.Have you ever had a drink first thing in 
the morning (an ‘eye opener’) to steady 
your nerves or get rid of hangover? 
 
 
5. Year of first consumption of alcohol:  
 
6. Chronicity of continuous intake of alcohol since: 
 
7. Stimulating factors: 
 
 
OTHERS 
 
PERSONAL HABITS YES NO 
IF YES 
SPECIFY 
DURATION 
AMOUNT/Qty 
Smoking     
Tobacco Chewing     
Narcotic Drug Addiction     
 
 
2) FAMILY HISTORY 
 
1. Whether this problem runs in family? 1. Yes            2. No 
 
   If yes, mention the relationship of 
affected   person 
1._________________ 
 
 
2._________________ 
 
 
2.Living with family or not 
 
 
3. Marital status: 
(married/unmarried/divorcee) 
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3) SOCIAL HISTORY: 
 
1. Felt any type of ignorance by society for drinking? 
2. If not able to fulfill your work because of drinking? 
3.Irregularity in normal duties: 
4. Mostly consume alone/friends:  
5. Trauma / Accidents met because of drinking: 
6. Criticized / Feeling guilty of mischievous activities if any  
 
4)OCCUPATIONAL HISTORY: 
 
Nature of job: 
 Whether your profession demands alcohol intake? 
 Do you work in your job with full statisfication/involvement? 
 How long do you work in same firm/company?   
 
 
 5) HISTORY OF FINANCIAL SATUS:  
 
A. Source of income : 
B. Part of income spent for alcohol:  
 
 
6)HISTORY OF PREVIOUS ILLNESS AND TREATMENT TAKEN: 
 
 
 
 
 
 
7)DIETARY STATUS: 
 
1.Vegetarian 
2.Non-vegetarian 
 
 
8)MENSTURAL AND OBSTETRIC 
HISTORY 
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FORM -II B 
CLINICAL ASSESSMENT PROFOMA 
 
GENERAL EXAMINATION: 
1. Body weight [Kg]            : 
2. Height [Cms]   : 
3. Body Temperature [F]     : 
4. Blood Pressure (mm/Hg): 
5. Pulse Rate /min. : 
6. Heart Rate / min.  : 
7. Respiratory Rate /min.: 
Yes       No 
8. Pallor   :   
9. Jaundice   :   
10. Clubbing   : 
11. Cyanosis   : 
12. Pedal Oedema   : 
13. Lymphadenopathy    :  
14. Jugular venous pulsation   : 
SYSTEMIC EXAMINATION 
 
  Cardiovascular system :  
  Respiratory system  :  
  Gastro-intestinal system :  
   Liver                                    : 
   Spleen                                  : 
Stomach                                 : 
Pancreas                                : 
Central Nervous system       : 
  Urogenital system  : 
Endocrine system  : 
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SIDDHA SYSTEM OF EXAMINATION 
1. THEGI (BODY CONSTITUTION): 
1. Vatha udal 
2. Pitha udal 
3. Kaba udal 
4. Thontha udal 
 
2. NILAM (LAND WHERE THE PATIENT LIVED MOST):  
1. Kurinji (Hilly terrain) 
2. Mullai (Forest range) 
3. Marutham (Plains) 
4. Neithal (Coastal belt) 
5. Paalai (Aridregion) 
3. KAALAM: 
1. Kaar kaalam             (Aavani-Purattasi) 
2. Koothir kaalam        (Ippasi-Kaarthigai) 
3. Munpani kaalam      (Maargazhi-Thai) 
4. Pinpani kaalam        (Maasi-Panguni) 
5. Ilavenil kaalam        (Chithirai-Vaigasi) 
6. Muthuvenil kaalam (Aani-Aadi) 
 
4. GUNAM: 
1. Sathuvam  
2. Rasatham 
3. Thamasam 
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5. PORIPULANGAL (SENSORY ORGANS):          
 
 
 
 
 
 
 
6.KANMENDRIYAM (MOTOR ORGANS) : 
 
 
 
 
 
 
 
 
 
 
7. KOSANGAL (SHEATH):           
 
 
 
8.SEVEN UDAL THAATHUKKAL (SEVEN SOMATIC COMPONENTS: 
 
 Before treatment After treatment 
Saaram Normal  /Affected Normal  /Affected 
Senneer  Normal  /Affected Normal  /Affected 
Oon Normal  /Affected Normal  /Affected 
Kozhuppu Normal  /Affected Normal  /Affected 
Enbu Normal  /Affected Normal  /Affected 
Moolai Normal  /Affected Normal  /Affected 
Sukkilam / Suronitham Normal  /Affected Normal  /Affected 
 
 
 Before treatment After treatment 
Mei (Skin) Normal  / Affected Normal  / Affected 
Vai (Tongue) Normal  / Affected Normal  / Affected 
Kann (Eye) Normal  / Affected Normal  / Affected 
Mooku (Nose) Normal  / Affected Normal  / Affected 
Sevi (Ear) Normal  / Affected Normal  / Affected 
 Before treatment After treatment 
Kai  Normal  /Affected Normal  /Affected 
Kaal  Normal  /Affected Normal  /Affected 
Vai    Normal  /Affected Normal  /Affected 
Eruvai  Normal  /Affected Normal  /Affected 
Karuvai  Normal  /Affected Normal  /Affected 
 Before treatment After treatment 
Annamaya kosam Normal  /Affected Normal  /Affected 
Pranamaya kosam  Normal  /Affected Normal  /Affected 
Manomaya kosam  Normal  /Affected Normal  /Affected 
Vignanamaya kosam  Normal  /Affected Normal  /Affected 
Ananthamaya kosam Normal  /Affected Normal  /Affected 
120 
 
 
 
9. UYIR THAATHUKKAL: [THREE HUMORS] (VALI/ AZHAL/ IYYAM) 
 
 
A) VALI 
 
 
0th 
day 
8th 
day 
15th 
day 
22nd 
day 
29th 
day 
36th 
day 
43rd 
day 
49th 
day 
Praanan         
Abaanan         
Samaanan         
Udhaanan         
Viyaanan         
Naagan         
Koorman         
Kirukaran         
Devathathan         
Dhananjeyan         
 
 
 
B) AZHAL 
 
0th 
day 
8th 
day 
15th 
day 
22nd 
day 
29th 
day 
36th 
day 
43rd 
day 
49th 
day 
Analakam         
Ranjakam          
Saathakam          
Prasakam          
Aalosakam         
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C) IYYAM 
 
 
 
10. ENVAGAI THERVU: [EIGHT TYPES OF EXAMINATION] 
 
I. NAADI: [PULSE PERCEPTION] 
 
NAADI 0thday 8th day 
15th 
day 
22ndday 29thday 36thday 43rdday 49thday 
         
 
 
 
 
II. SPARISAM: [PALPATION] 
 
Day SPARISAM 
0thday  
8th day  
15thday  
22ndday  
29thday  
36thday  
43rdday  
49th day  
 
 
 
0th 
day 
8th 
day 
15th 
day 
22nd 
day 
29th 
day 
36th 
day 
43rd 
day 
49th 
day 
Avalambagam         
Kilethagam         
Pothagam         
Tharpagam         
Santhigam         
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III. NAA: [TONGUE] 
 
NAA 0thday 8thday 15thday 22ndday 29thday 36thday 43rdday 49thday 
         
 
 
 
IV. NIRAM: [COMPLEXION] 
 
 1. Vadham         
 2. Pitham 
 3. Kabam 
 
 
V. MOZHI: [VOICE] 
 
1. High Pitched 
2. Low Pitched 
3. Medium Pitched 
 
VI.VIZHI: [EYES] 
 
VIZHI 0th day 8th day 15thday 22ndday 29thday 36th day 43rdday 49thday 
         
 
 
VII. MALAM: [BOWEL HABITS / STOOLS] 
 
 
 Before treatment After treatment 
Niram   
Irugal   
Ilagal   
Others   
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VIII. MOOTHIRAM [URINE EXAMINATION]  
 
NEERKKURI: 
 
Neerkkuri Before treatment After treatment 
Niram   
Manam   
Edai   
Nurai   
Enjal   
 
 
NEIKKURI:  
 
Neikkuri Before treatment After treatment 
 Aravana needathu/ 
Snake like pattern 
 
  
Azhipol paraviyathu 
Annular/Ringedpattern 
 
 
 
parav 
paraparavoiyadu 
  
Muththothu ninrathu  
Pearlbeadepattern 
  
Other p tterns   
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 CLINICAL ASSESSMENT DURING & AFTER TRIAL 
 
1. OP/ IP NO: …………       2. SL. NO: 
………   
3.NAME: ………………………….           4. AGE/GENDER: ………  
6. DATE OF RECRUITMENT: …… 
 
CLINICAL EXAMINATION:  
 
A. HEALTH ASSESSMENT QUESTIONNAIRE: 
 0th day 8th day 15th day 
22ndda
y 
29th 
day 
36th 
day 
43rdday 
49th 
day 
A.Intoxication 
(present/absent) 
        
B.Harmful use 
(present/absent) 
        
C. Craving of 
alcohol   
(Absent/Mild/ 
Moderate/ 
Severe) 
        
D.Withdrawal 
symptom 
(present/absent) 
        
E.Negligence of 
activity 
(Present/absent) 
        
F.Time spent in 
alcohol- related 
activity 
(Present/absent) 
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G.Family and 
Social status 
(Poor/Normal/ 
Developed) 
        
H.Loss of 
appetite 
(Present/absent) 
        
I.Nausea,vomiti
ng 
(Present/absent) 
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CLINICAL ASSESSMENT BEFORE AND AFTER TRIAL 
B. Alcohol use disorder identification test (AUDIT) 
The Alcohol Use Disorders Identification Test (AUDIT), developed in 1982 by the 
World 
Health Organization, is a simple way to screen and identify people at risk of alcohol 
Problems. 
 
BEFORE AFTER 
TRIAL TRIAL 
1. How often do you have a drink containing alcohol?    
(0) Never (Skip to Questions 9-10) 
(1) Monthly or less 
(2) 2 to 4 times a month 
(3) 2 to 3 times a week 
(4) 4 or more times a week 
 
3. How many drinks containing alcohol do you have on a typical 
 day when you are drinking?        
(0) 1 or 2 
(1) 3 or 4 
(2) 5 or 6 
(3) 7, 8, or 9 
(4) 10 or more 
 
3. How often do you have six or more drinks on one occasion? 
(0) Never 
(1) Less than monthly 
(2) Monthly 
(3) Weekly 
(4) Daily or almost daily 
 
 
127 
 
4. How often during the last year/Treatment period have you found that you 
were not able to stop drinking once you had started? 
(0) Never 
(1) Less than monthly 
(2) Monthly 
(3) Weekly 
(4) Daily or almost daily 
 
5. How often during the last year/Treatment period have you failed to do what 
was normally 
expected from you because of drinking? 
(0) Never 
(1) Less than monthly 
(2) Monthly 
(3) Weekly 
(4) Daily or almost daily 
 
6. How often during the last year/Treatment period have you been unable to 
remember what happened the night before because you had been drinking? 
(0) Never 
(1) Less than monthly 
(2) Monthly 
(3) Weekly 
(4) Daily or almost daily 
 
7. How often during the last year/Treatment period have you needed an alcoholic 
drink first thing in the morning to get yourself going after a night of heavy 
drinking? 
(0) Never 
(1) Less than monthly 
(2) Monthly 
(3) Weekly 
(4) Daily or almost daily 
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8. How often during the last year have you had a feeling of guilt or remorse 
after drinking? 
(0) Never 
(1) Less than monthly 
(2) Monthly 
(3) Weekly 
(4) Daily or almost daily 
 
9. Have you or someone else been injured as a result of your drinking? 
(0) No 
(2) Yes, but not in the last year 
(4) Yes, during the last year 
 
10. Has a relative, friend, doctor, or another health professional expressed 
concern about your drinking or suggested you cut down? 
(0) No 
(2) Yes, but not in the last year 
(4) Yes, during the last year 
 
Add up the points associated with answers. A total score of 8 or more indicates 
harmful 
drinking behavior. 
Total  no of scoring-  
 
Score  0-7 :  No risk 
  
Score  8-15 :   Mild risk 
  
 Score 16-19 :   Moderate risk 
 
 Score 20-40 :   Severe risk  
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Date:          
Station: 
Signature of the Investigator: 
 
Signature of the Lecturer:                              Signature of the HOD:                          
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NATIONAL INSTITUTE OF SIDDHA 
AYOTHIDOSS PANDITHAR HOSPITAL, CHENNAI – 600 047. 
 
POST-GRADUATE DEPARTMENT OF SIRAPPU MARUTHUVAM 
 
An open clinical trial to Evaluate the Therapeutic Efficacy of Siddha Herbal 
formulation Inji Chooranam for the treatment of Kudiverinoi(Chronic Alcoholism)” 
 
Principal Investigator:  
 
Reg. No: 
 
 
.FORM-IIILABORATORY INVESTIGATIONS 
 
BLOOD INVESTIGATIONS 
NORMAL 
VALUES 
BEFORE 
TREATMENT 
AFTER 
TREATMENT 
Hb( gm/dl) 
M:13-18 
W:11-16 
  
T.RBC(millions cells /Cu.mm) 
M:4.5-6.5 
W:3.5-5.5 
  
ESR (mm) 
½ hr. -   
1 hr. 
M:0-10 
W:0-20 
  
T.WBC (Cells /Cu.mm) 4000-11000   
Differential 
Count (%) 
Polymorphs 40-75   
Lymphocytes 20-35   
Monocytes 2-10   
Eosinophils 1-6   
Basophils 0-1   
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BLOOD INVESTIGATIONS 
NORMA
L 
VALUES 
BEFORE 
TREATMEN
T 
AFTER 
TREATMEN
T 
Blood 
glucose 
(mg/dl) 
Fasting 70-110   
PP 80-140   
Lipid 
profile 
(mg/dl) 
Serum cholesterol 150-200   
HDL 30-60   
LDL Up to 130   
VLDL 40   
TGL Up to 160   
RFT 
(mg/dl) 
Blood urea 16-50   
Serum creatinine 0.6-1.2   
LFT 
(mg/dl) 
Total bilirubin 0.2-1.2   
Direct bilirubin 0.1-0.2   
Indirect bilirubin 0.2-0.7   
Total protein 6-8   
Serum Albumin 3.5-5.5   
Serum globulin 2-3.5   
SGOT (IU/L) 0-40   
SGPT (IU/L) 0-35   
Alkaline phosphatase 
(IU/L) 
80-290   
 
Serum calcium 9-11   
Serum phosphorus 2-5   
Serum Uric acid 
M:3-9 
W: 2.5-7.5 
  
 CRP   
 ASO titre   
 RA factor   
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B. URINE INVESTIGATIONS: 
 
URINE 
INVESTIGATIONS 
BEFORE TREATMENT 
AFTER 
TREATMENT 
Albumin   
Sugar (Fasting) 
        (PP) 
  
Deposits   
Bile salts   
Bile pigments   
   
 
 
SPECIFIC INVESTIGATIONS: 
 
Gamma-glutamyl-transpeptidase (GGT)  : 
 
Blood alcohol concentration   : 
 
USG-abdomen     : 
 
 
Date:          
Station: 
 
 
 
 
 
Signature of the Investigator: 
 
 
 
 
 
 
Signature of the Lecturer:        
        Signature of the HOD 
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NATIONAL INSTITUTE OF SIDDHA 
AYOTHIDOSS PANDITHAR HOSPITAL, CHENNAI – 600 047. 
 
POST-GRADUATE DEPARTMENT OF SIRAPPU MARUTHUVAM 
 
An open clinical trial to Evaluate the Therapeutic Efficacy of Siddha Herbal 
formulation Inji Chooranam for the treatment of Kudiveri Noi (Chronic 
Alcoholism)” 
 
Name of Principal Investigator:     Reg. No : 
 
CONSENT FORM    -   FORM VI 
 
 
“I have read the foregoing information, or it has been read to me. I have 
had the opportunity to ask questions about it and any questions I have asked have 
been answered to my satisfaction.  
            I consent voluntarily to participate as a participant in this study and 
understand that I have the   right to withdraw from the study at any time without in 
any way it affecting my further medical care”. 
 
"I have received a copy of the information sheet/consent form". 
 
Date:  
 
Signature of the participant: 
In case of illiterate participant: 
 
        “I have witnessed the accurate reading of the consent form to the potential 
participant, and the individual has had the opportunity to ask questions. I confirm 
individual has given consent freely.”                                                   
Date: 
 
Signature of a witness  
(Selected by the participant bearing no connection with the survey team)  
       
 
 
 
 
Left thumb Impression of the Participant 
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FORM V – PATIENT INFORMATION SHEET 
 
 
Name of Principal Investigator:     Reg. No : 
 
Name of the institute: National Institute of Siddha, 
                                      Tambaram Sanatorium, 
                                      Chennai-47. 
 
INFORMATION SHEET FOR PATIENTS PARTICIPATING IN THE OPEN 
CLINICAL TRIAL. 
 
I, Dr. S. UTHRAPATHI   Studying M.D (Siddha) at National Institute of 
Siddha, Tambaram Sanatorium is doing a trial on KUDIVERI NOI (CHRONIC 
ALCOHOLISM).Alcoholism is a most common psychiatric disease, occurring 
throughout the world. In this regard, I am in a need to ask you few questions. I will 
maintain confidentiality of your comments and data obtained. There will be no risk of 
disclosing your identity and no physical, psychological or professional risk is 
involved by taking part in this study. Taking part in this study is voluntary. No 
compensation will be paid to you for taking part in this study. 
           You can choose not to take part. You can choose not to answer a specific 
question. There is no specific benefit for you if you take part in the study. However, 
taking part in the study may be of benefit to the community, as it may help us to 
understand the problem of defaulters and potential solutions. 
             If you agree to be a participant in this study, you will be included in the study 
primarily by signing the consent form and then you will be given the internal 
medicine Inji Chooranam for the treatment of Kudiveri Noi (Chronic Alcoholism)” 
 The information I am collecting in this study will remain confidential. I will 
ask you few questions through a questionnaire.  
If you wish to find out more about this study before taking part, you can ask 
me all the questions you want or contact Dr.S.UTHRAPATHI PG Scholar cum 
principal investigator of this study, attached to National Institute of Siddha, Chennai-
47. You can also contact the Member-secretary of Ethics committee, National 
Institute Siddha, Chennai 600047, Tel No: 7358804064, for rights and participation in 
the study. 
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NATIONAL INSTITUTE OF SIDDHA 
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An open clinical trial to Evaluate the Therapeutic Efficacy of Siddha Herbal 
formulation Inji Chooranam for the treatment of Kudiverinoi (Chronic Alcoholism)” 
 
 
Name of Principal Investigator:     Reg. No : 
 
FORM  -VIII  DIETARY ADVICE FORM 
 
 
§º÷ì¸ ÜÊÂ ¯½×¸û ¾Å¢÷ì¸ §ÅñÊÂ¨Å¸û 
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NATIONAL INSTITUTE OF SIDDHA 
AYOTHIDOSS PANDITHAR HOSPITAL, CHENNAI – 600 047. 
 
POST-GRADUATE DEPARTMENT OF SIRAPPU MARUTHUVAM 
 
An open clinical trial to Evaluate the Therapeutic Efficacy of Siddha Herbal 
formulation Inji Chooranam for the treatment of Kudiveri noi (Chronic 
Alcoholism)” 
 
Name of Principal Investigator:     Reg. No : 
 
FORM VII - WITHDRAWAL FORM 
 
1. SERIAL NO OF THE CASE: …………………   
2. OP / IP NO: ......................................   
3. NAME: ………………………    
4.AGE: …………        
5.GENDER:...........                           
6. DATE OF TRIAL COMMENCEMENT: ………………... 
7. DATE OF WITHDRAWAL FROM TRIAL: …………….. 
8. REASONS FOR WITHDRAWAL: 
Long absence at reporting:              Yes/ No 
Irregular treatment:                          Yes/ No 
Shift of locality:                                    Yes/No 
Increase in severity of symptoms:    Yes/No 
Development of severe adverse drug reactions:  Yes/No 
Development of adverse event :   Yes/No                                        
 
Date:          
Station: 
 
Signature of the Lecturer:  
 
Signature of the Investigator:       
        Signature of the HOD  
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An open clinical trial to Evaluate the Therapeutic Efficacy of Siddha Herbal 
formulation Inji Chooranam for the treatment of Kudiverino (iChronic Alcoholism)” 
 
Name of Principal Investigator:     Reg. No: 
 
ADVERSE REACTION FORM 
 
SERIAL NO:                                                                                                           
OP/IP NO: 
NAME:          AGE:   GENDER: 
DATE OF TRIAL COMMENCEMENT: 
DATE OF THE ADVERSE REACTION OCCUR: 
DESCRIPTION OF ADVERSE REACTION: 
 
 
 
Date:                                                                              
Station:  
 
Signature of the Investigator: 
 
 
 
Signature of the Lecturer:    
         Signature of the HOD 
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NATIONAL INSTITUTE OF SIDDHA 
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POST-GRADUATE DEPARTMENT OF SIRAPPU MARUTHUVAM 
 
  An open clinical trial to Evaluate the Therapeutic Efficacy of Siddha 
Herbal formulation Inji Chooranam for the treatment of Kudiverinoi (Chronic 
Alcoholism)” 
 
 
Name of Principal Investigator:     Reg. No : 
 
FORM - IV (DRUG COMPLIANCE FORM) 
SERIAL NO: 
NAME:  
DRUG NAME:  
 
 
On 1st     day-Date:  Drugs issued:      Drugs returned 
On 8th   day-Date:   Drugs issued:      Drugs returned:  
On 15th day-Date:              Drugs issued:      Drugs returned:  
On 22th day-Date:            Drugs issued:      Drugs returned:  
On 29th day-Date:             Drugs issued:      Drugs returned:  
On 36th day-Date:              Drugs issued:      Drugs returned:  
On 43th day-Date:                   Drugs issued:      Drugs returned:  
 
   Day    Date    Morning   Evening   Day     Date    Morning   Evening 
Day 1    Day6    
Day2    Day7    
Day3    Day8    
Day4    Day9    
Day5    Day10    
Day11    Day30    
Day12    Day31    
Day13    Day32    
Day14    Day33    
Day15    Day34    
Day16    Day35    
Day17    Day36    
Day18    Day37    
Day19    Day38    
Day20    Day39    
Day21    Day40    
Day22    Day41    
Day23    Day42    
Day24    Day43    
Day25    Day44    
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Date:          
Station: 
 
 
Signature of the Investigator: 
 
 
 
 
 
 
 
Signature of the Lecturer:   
    Signature of the HOD 
 
 
 
Day26    Day45    
Day27    Day46    
Day28    Day47    
Day29    Day 48    
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Certificate for Research methodology and Biostatics: 
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Certificate for IEC 
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Authendication certificate for Inji choornam (Trial drug) 
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